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Abstract 
Cyclotides are plant derived macrocyclic peptides featuring a cyclic cystine knot (CCK) 
formed by six cysteine residues on a head-to-tail cyclic backbone. Their unique structural 
features make them exceptionally stable against thermal, enzymatic or chemical degradation. 
Naturally isolated cyclotides have many pharmaceutically important activities, including 
uterotonic, anti-HIV, antimicrobial and anticancer properties. The combination of structural 
features and biological activities make cyclotides an attractive framework in drug design 
applications.  
 
To date over 300 cyclotides have been discovered in five plant families: Violaceae, 
Rubiaceae, Cucurbitaceae, Fabaceae and Solanaceae. However, their origin and distribution 
in the plant kingdom remains unclear. In this thesis a total of 206 plants belonging to 46 
different plant families have been screened for expression of cyclotides. In this screening 
program, 50 novel cyclotides were discovered from 31 plant species belonging to the 
Rubiaceae and Violaceae families. Interestingly, all the Violaceae species possess cyclotides 
supporting the hypothesis that the Violaceae is a rich source of cyclotides. As a matter of fact, 
cyclotides have been found in every plant species belonging to the Violaceae family screened 
so far.  
 
It is noteworthy that a novel suite of Lys-rich cyclotides were discovered from Melicytus 
chathamicus and M. latifolius belonging to the Violaceae family which are endemic to remote 
islands of Australia and New Zealand. Unlike generic cyclotides, Lys-rich cyclotides possess 
higher positive charge, which correlates with their earlier retention times in RP-HPLC 
indicative of lower hydrophobic properties.  
 
 ii 
 
The broad spectrum of biological activities of cyclotides suggests the involvement of a 
common mechanism of action. Earlier studies have demonstrated that cyclotides exert 
biological activities through interaction with biological membranes. In order to understand 
the mode of action of novel cyclotides, membrane binding, and membrane permeabilization 
properties were evaluated on model membranes using a range of biophysical techniques 
including surface plasmon resonance (SPR), fluorescence spectroscopy and cryo-
transmission electron microscopy (cryo-TEM). Regardless of their sequence diversity all of 
the cyclotides showed affinity towards phospholipids containing a phosphatidylethanolamine 
(PE) headgroup, which is in agreement with previous studies. In comparison to typical 
cyclotides, Lys-rich cyclotides display relatively lower haemolytic activities and 
correspondingly these peptides also showed lower affinities with model membranes. These 
results support the theory that membrane binding affinities influence the biological activities. 
 
The spectroscopic studies clearly show that cyclotides do target and disrupt membranes. 
However, the complete membrane disruption mechanism has not been evaluated yet. In this 
thesis, cyclotide-membrane interactions were investigated using cryo-TEM imaging. The 
results suggest that the membrane disruption mechanism is sequence dependent.  
 
Overall, the thesis has provided an increased understanding of the natural diversity of 
cyclotides and has added to our understanding of their mode of action. In particular, the 
discovery of a novel family of Lys-rich cyclotides suggests that there might be other new 
types of cyclotides yet to be discovered. Hence, discovery and characterization of cyclotides 
in this field of research has much to offer.  
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Cyclotides 
 
Chapter 1:  Introduction 
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1.1 Circular proteins in nature 
Peptides are usually considered as a linear polymer of amino acids with free amino (NH2) and 
carboxyl (COOH-) termini. Unlike linear peptides, circular proteins have been discovered 
with both termini connected together forming a head-to-tail circular backbone [1]. They exist 
in nature with a range of 7 to 70 AA in size and divergent structures [1]. Due to the presence 
of the circular backbone, they are highly resistant to proteolytic enzymes and harsh 
physiological conditions, including high temperatures and extreme pH, and thus they have 
attracted interest in drug design applications [1]. Several naturally occurring circular 
peptides/mini proteins have been discovered among bacteria, plants and animals [1, 2]. 
Despite their diversity in origin, it is believed that circular peptides have a common role as 
defence agents in the organisms where they are expressed [2]. 
 
One of the largest circular proteins, bacteriocin AS-48, is 70 AA in size and was isolated 
from Enterococcus faecalis, where it functions as an antibacterial peptide [3]. Its three-
dimensional structure, comprising a hydrophobic core surrounded by five α-helices and a 
circular backbone, accounts for its high stability and resistance to high temperatures [4]. 
Similarly to bacteria, mammals also express circular peptides that seem to have a defensive 
role. An example is a defensin molecule termed theta defensin-1 (RTD-1) with 18 AA in 
length expressed in Rhesus macaque [5]. Unlike bacteriocin AS-48 RTD-1 features three 
disulfide bonds with a ladder-like arrangement on a circular backbone. Linearisation of the 
circular backbone in RTD-1 did not introduce any significant changes in overall structure. 
However, in respect to antibacterial activity, an acyclic form of RTD-1 showed three fold 
lower activity than the native cyclic version [5].  
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Plants have been regarded as a power house of molecules displaying a range of therapeutic 
properties. In recent years, plant derived disulfide-rich proteins received significant attention 
in drug design due to their unique structural and functional properties. For instance, 
sunflower trypsin inhibitor-1 (SFTI-1), a small 14 AA circular peptide isolated from 
Helianthus annuus (Asteraceae family), features a well-defined structural architecture and 
displays trypsin inhibitory activity at sub-nanomolar levels [6]. Cyclotides are a large family 
of plant derived disulfide-rich circular peptides with pharmaceutically important activities 
[7]. The prime focus of the current thesis is to understand diversity and distribution of 
cyclotides in plants and their mechanism of action towards cells.  
 
1.2 Cyclotides 
 
Cyclotides [7] are plant derived disulfide-rich mini-circular proteins featuring a cyclic cystine 
knot (CCK) formed by six cysteine residues on head-to-tail cyclic backbone [7]. Typically, 
cyclotides are 28-37 amino acids in size and representative sequences are provided in Table 
1.1. The typical three dimensional structure with the CCK motif is illustrated with the 
prototypic cyclotide kalata B1 [8] in Figure 1.1.  
 
Figure 1.1 Sequence and three dimensional structure of the prototypic 
cyclotide kalata B1. (A) The amino acid sequence of kalata B1 showing the 
six Cys residues (labelled with Roman letters I-VI), the disulfide connectivity 
and the cyclic backbone. (B) Three dimensional structure of kB1 (Protein 
Data Bank ID code INB1). The segments between two adjacent Cys residues 
are named loops and are numbered 1 to 6. The peptide backbone is 
circularised by a peptide bond between gly-1 and asn-29 in loop 6. (This 
figure is adopted from [8]). 
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Naturally isolated cyclotides have been reported to exhibit a range of biological activities, 
including cytotoxicity towards cancer cell lines [9], uterotonic [8] and anti-HIV activities 
[10]. The combination of unique structural properties along with their biological activities has 
attracted interest in drug design applications. 
 
1.2.1 Initial discovery of cyclotides 
The discovery of cyclotides initially occurred in the early 1970s by a Norwegian doctor, 
Lorents Gran [11]. Dr. Gran noticed Congolese women drinking a tea “Kalata-kalata” [11] 
prepared from the leaves of Oldenlandia affinis (O. affinis), a plant species that belong to the 
Rubiaceae family. Subsequent analysis of that decoction had led to the discovery of a heat 
stable uterotonic polypeptide named kalata B1 (kB1) [12]. The original study carried out by 
Dr. Gran, revealed uterotonic activity of O. affinis extract on human uterine muscle and rat 
uterus [11]. However, complete structural and biophysical properties of cyclotides remained 
unknown until Saether et al. characterised the structure of kB1 [8]. Subsequently, more than 
300 cyclotides have been sequenced from plant species of the Rubiaceae, Violaceae, 
Cucurbitaceae, Fabaceae and Solanaceae. All sequences are available in cybase, a database 
dedicated to cyclic peptides www.cybase.org.au [13]. 
 
1.2.2 Classification of cyclotides 
Cyclotides are grouped as Möbius or bracelet based on their topology [7] (Table 1.1). 
Möbius cyclotides are identified through the presence of a conserved cis-Pro residue in loop 
5, while those lacking the cis-Pro bond are termed bracelet cyclotides. The presence of a cis-
Pro residue induces a 180
o
 twist architecture, a topological entity known as Möbius strip in 
members of the Möbius subfamily. On the other hand, the absence of cis-Pro introduces a 
ribbon topology referred to as bracelet [14]. In addition to this conceptual topological 
Chapter 1:  Introduction 
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difference, both subfamilies can be further distinguished by their variation in loop size and 
sequences. With the exception of loop 4, the remaining five loops of Möbius subfamily 
members possess at least one conserved residue; in fact about 60% of the residues are highly 
conserved [15]. On the other hand, bracelet subfamily members possess a Glu residue in loop 
1 and a terminal Pro in loop 2 that are highly conserved [13]. These two subfamilies can also 
be differentiated based on the global net charge. For instance, bracelet subfamily members 
are more positively charged due to the presence of Lys and/or Arg residues in loops 5 and 6 
[13, 16]. Most Möbius cyclotides are overall neutral and contain few charged residues [16]. 
 
Table 1.1 Cyclotide sequences from different subfamilies 
 
Trypsin inhibitors are a third subfamily of cyclotides identified in squash plants [17]. MCoTI-
I and II are examples of trypsin inhibitors that were isolated from seeds of Momordica 
cochinchinensis, a plant species belonging to the Cucurbitaceae family [17]. Although 
members of this subfamily do not share any sequence homology with Möbius and bracelet 
subfamilies [18], their CCK pattern and cyclisation mechanism lead them to be included in 
Chapter 1:  Introduction 
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the cyclotide family. Cyclotides in the trypsin inhibitor subfamily are relatively more 
hydrophilic than members of the Möbius and bracelet subfamilies [18]. The hydrophilic 
properties of these cyclotides are due to the presence of more positively-charged residues and 
a lower proportion of hydrophobic residues. 
 
1.2.3 Nomenclature of cyclotides 
Cyclotides are unambiguously the largest known family of plant-derived cyclic peptides [13]. 
In recent years, there has been a growing academic interest in the discovery and 
characterisation of novel cyclotides around the globe. Hence, it is important to have a suitable 
naming system in order to overcome the name redundancy problem. For instance, cyclotides 
kalata S and varv peptides A, and varv peptide E and cycloviolacin O12 were named 
differently, but they have same sequence. As a matter of fact, these cyclotides were identified 
from distinct plant species in different individual studies, but their sequences were redundant.  
 
Many nomenclature systems have been used to name cyclotides. However, the naming 
system proposed by Broussalis and co-workers is often widely accepted [19]. According to 
their nomenclature, names of newly discovered cyclotides are derived from the Latin 
scientific name of plant from which they are first isolated and followed by an alphabetic letter 
or a numeric to indicate order of appearance. For example, as shown in Scheme 1 Hypa A is 
a cyclotide from Hybanthus parviflorus; the name was derived from the first two letters (Hy) 
in genus Hybanthus and last two letters in species name (“pa”). Alphabet “A” represents the 
order of cyclotide [19]. In the current thesis, all the newly discovered cyclotides were named 
according to this nomenclature. 
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        Scheme 1: nomenclature of cyclotides 
 
 
1.2.4 Biosynthesis of cyclotides 
Many ribosomal and non-ribosomal circular proteins had been found before the discovery of 
cyclotides [20]. For instance, cyclosporine and bacitracin are synthesised by non-ribosomal 
synthases [21]. On the other hand, bacteriocin AS-48 is a ribosomally synthesised circular 
protein [3]. The biosynthetic mechanism of cyclotides was unknown until 2001, when 
Jennings et al. reported four precursors Oak 1-4, generated from the cDNA library obtained 
from leaves of O. affinis [22]. Subsequently, many cyclotide precursor sequences from other 
plant families including Violaceae [23, 24], Fabaceae [25], Cucurbitaceae [17] and 
Solanaceae [26]  provided more information on the biosynthesis of cyclotides.  
The typical structure of cyclotide precursor proteins from several plant families is illustrated 
in Figure 1.2. As can be seen, all the cyclotide precursors start with endoplasmic reticulum 
(ER) signal peptide followed by N-terminal propeptide, N-terminal repeat (NTR), cyclotide 
domain and end with C-terminal propeptide (CTR) [24]. The presence of an endoplasmic 
reticulum signal suggests that the precursor enters into secretory pathway where disulfide 
bond formation and folding occurs. The cyclotide domain occurs between the N-terminal 
repeat and C-terminal propeptide residues. The NTR region is highly conserved in all 
cyclotide-bearing plant species, suggesting that it is crucial for cyclotide processing. A 
precursor can encode for a single or multiple cyclotides. For instance, precursor Oak1 
encodes only kalata B1, while Oak4 encodes three copies of kalata B2 [22].  
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Figure 1.2: Schematic comparision of typical cyclotide precursors structures from Violaceae, 
Fabaceae, Solanaceae and Rubiaceae. (A) The typical structure of a cyclotide precursor possesses 
endoplasmic reticulum signal (ER), N-terminal propeptide (NTPP), N-termini repeat (NTR) region, 
cyclotide domain and C-termini repeat (CTR) region (TAIL). A single precursor may have one or 
multiple copies of the same cyclotide or it can process different cyclotides domains. The precursor 
structures of cyclotides cycloviolacin O8, cter M, phyb A and kalata B1 and their respective families 
are shown. (B) The conserved residues in NTR and CTR suggest involvement of enzymatic cleavage 
and cyclization of cyclotide domain from the precursor protein. 
 
The structure of cyclotide precursors from the Fabaceae plant family [25] is different from 
precursors from the Violaceae and Rubiaceae family plants. For instance, in the precursor 
protein of cter M the regular cyclotide domain replaces an albumin-1 gene domain. In plants, 
albumins are nutrient reservoirs commonly processed by asparaginyl endoproteinase  (AEP) 
enzymes [25]. The gene structure of typical albumins comprises an ER signal, chain-b, a 
linker gene and chain-a. In precursor proteins of cter M the albumin chain-b is replaced with 
a cyclotide domain [25]. It was hypothesised that the unusual occurrence of the cter M 
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domain is due to successive evolution from one protein domain to another or a sudden lateral 
transfer of a cyclotide domain in albumin gene. Fabaceae is the third largest plant family and 
comprises several medically, economically and agriculturally important plants [27]. The 
discovery of cyclotide precursors in C. ternatae shed light on potential agricultural benefits of 
cyclotides in plants belonging to the Fabaceae family [28].  
 
From a series of studies [22, 29], it has been very clear that cyclotides are ribosomally 
synthesised via precursor proteins (Figure 1.2). However, the complete details of excision 
and cyclisation events in plants are not very well understood. It has been believed that AEP is 
involved in processing mature cyclotides from precursor proteins [2]. This hypothesis is 
supported by the ubiquity of AEP in plants and by the highly conserved Asp or Asn residue at 
the C-terminus of the mature peptide sequence in the precursor (Figure 1.2). Furthermore, 
site specific mutagenesis and gene silencing studies carried out in model transgenic plants 
support AEP activity [2]. Another recent study demonstrated the processing mechanism of 
SFTI-1, a cyclic peptide trypsin inhibitor from sunflower seeds, involving cyclization with 
AEP and identical to the one proposed for cyclotides [3].  
 
1.2.5       Biological activities  
The biological activities of cyclotides have been explored through a series of bioassay-guided 
fractionation studies of plant species with medicinal value [11, 12]. For instance, the 
uterotonic activity of the prototypic cyclotide kB1 [12] was revealed in bioactivity guided 
fractionation [11]. Subsequent screening program for the discovery of anti-HIV agents led to 
the discovery of circulin A and circulin B from Chassalia parvifolia [30]. In similar studies, 
several other biological activities, including antimicrobial [31], cytotoxicity towards cancer 
cell lines [9] and haemolytic activities [32] were discovered. Cyclic peptides produced in 
Chapter 1:  Introduction 
10 
 
other organisms, including mammals, bacteria and fungi are believed to have common roles 
as defence agents [33]. Accordingly, it has been hypothesised that cyclotides act as defence 
agents in plants against pests [22]. 
 
Kalata B1 is the first known cyclotide characterised for its insecticidal properties, inhibiting 
the growth and development of Helicoverpa and eventually leading to death [22]. Paradigin-
br-1, a cyclotide isolated from Palicourea rigida (Rubiaceae), has shown potential in vitro 
and in vivo insecticidal activities. For instance, when neonate larvae of Lepidoptera (Diatraea 
saccharalis) were fed with 1 μM of paradigin-br-1, a significant reduction in growth of larvae 
was observed [4]. Concentration dependent (1,5 and 10 μM) in vitro insecticidal studies on 
Spodoptera frugiperda (SF-9) revealed a decreased cell viability proportional to peptide 
concentrations [4]. A recent review in which I am a co-author summarises the many other 
potential biological activities of individual cyclotides [34]. 
 
1.2.6 Drug design applications  
The biological activities and extraordinary stability of cyclotides against acid, temperature 
and proteases has attracted significant interest in drug design applications [35]. The low yield 
of cyclotides in plants is a challenge in some of these studies. Hence, efficient syntheses of 
cyclotides with significant yield play an important role in drug design and in characterising a 
range of biophysical properties. 
 
Cyclotides are ribosomally synthesised and gene-encoded macrocyclic peptides in plants and 
their biosynthesis mechanism is described in previous sections. Biosynthesis of cyclotides on 
a large scale has been inefficient in studies reported so far. On the other hand, an increasing 
number of chemical synthesis methods enable the synthesis of cyclotides with active epitopes 
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incorporated into the stable knottin structure. Particularly, solid phase peptide synthesis 
(SPPS) is one of the robust approaches that is widely used in the synthesis of cyclotides [34] 
(Figure 1.3). 
 
 
 
Figure 1.3: Solid phase peptide synthesis strategy for the cyclotide framework. The complete 
three-dimensional structure of cyclotide is achieved in three steps including (1) synthesis of linear 
precursor of selected peptide assembled with thioester linker at C-terminal; (2) thioester/thiol 
exchange between the cys-residues in the backbone to the carbonyl group at C-terminal contributing 
to ring expansion; (3) the final step includes migration of S,N-acyl by generating peptide bond 
between N- and C- termini followed oxidation of cysteine residues on the backbone. 
 
 
 
 
 
Chapter 1:  Introduction 
12 
 
Synthesis of cyclotides using SPPS involves a series of steps:  
Step 1:  Synthesis of a linear precursor of a desired cyclotide with a Cys residue at the 
N-terminus and a thioester linker at the C-terminus. 
Step 2:  It has been postulated that cyclisation involves autocatalytic ligation through a 
series of thiol-thiolacetone exchanges followed by zipping of N-terminus and 
C-terminus [36].  
Step 3:  Following the formation of the thioester between the N- and C- termini, an  
S→N acyl migration results complete oxidation of cysteine residues [36].  
 
This method is robust and complete oxidation of disulfide bonds and head-to-tail cyclisation 
can be achieved in “one pot” medium. Cyclotides, including kB1, kalata B2, MCoTI-I/II and 
several other mutated scaffolds have been synthesised for drug design applications using this 
method [37]. However, here I exemplify with chemical mutagenesis of kB1 and MCoTI-II 
and their pharmaceutical drug design applications. 
 
 
Figure 1.4: Illustrates the incorporation of biologically active epitopes and primary sequences of interest in 
CCK templates of (A) kalata B1 and (B) McoTI-II. 
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Kalata B1 was the first Möbius cyclotide used to design antiangiogenic agents by grafting an 
active epitope sequence, RRKRRR (poly-R), (Figure 1.4 A) and showed inhibitory activity 
against vascular endothelial growth factor receptor 2 (VEGFR2) [38]. Vascular endothelial 
growth factor (VEGF) is a signalling protein that plays a major role in angiogenesis 
(generation of new blood vessels). However, overexpression of VEGF contributes to the 
development of lethal diseases, including cancer. Various analogues were designed by 
incorporating the poly-R epitope into loops 2, 3, or 6. Among all the grafted cyclotides, an 
analogue with the poly-R sequence in loop 3 (Figure 1.4 A) showed significant inhibitory 
activity against VEGF at an IC50 of 12 μM. Furthermore, stability studies revealed that the 
circular version of the poly-R sequence grafted peptide was more stable than the linear 
precursor [38]. Hence, VEGF inhibitors have potential applications in development of cancer 
therapeutics [38].  
 
In addition to Möbius subfamily members, cyclotides belonging to the trypsin inhibitor 
subfamily have also been used as templates in drug design applications. For instance, 
naturally isolated MCoTI-I and MCoTI-II scaffolds have significant trypsin inhibitory 
activity, and engineering of these scaffolds further made them highly potent inhibitors 
displaying pM (picomolar) activity [39]. Ecballium elaterium trypsin inhibitor II (EETI-II) is 
a squash inhibitor family member with potent trypsin inhibitor activity [40]. Studies have 
suggested that a positively charged residue Lys located in position 1 of the substrate binding 
site is a key determinant for its activity. This position is homologous to the Lys located in 
position 10 of MCoTI-I/II. Taking this analogy and advantages of chemical synthesis 
techniques, a systematic mutagenesis study was carried out for enhanced protease inhibitory 
activities. Following replacement of Lys-10 with Phe, the trypsin inhibitor activity was 
switched to chymotrypsin inhibitory activity [41]. Interestingly, when this position was 
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replaced with Gln or Ala-Lys-Gln, the analogues MCoTI-II[Q] and MCoTI-II[AKQ] 
exhibited activity against 3C protease derived from foot-and-mouth disease virus (FMDV 
3C) [41]. MCoTI-II[Q] and  MCoTI-II[AKQ] are regarded as the first protease inhibitor- 
based antagonists developed against virulent pathogens [41] (Figure 1.4 B). 
 
The natural sequence diversity of cyclotides, their biological activities and their plasticity for 
mutagenesis, together with improved strategies for peptide synthesis, has prompted the 
potential use of the cyclotide framework for peptide based drug design applications.  
 
1.2.7 Mechanism of action of cyclotides 
To date, several hundred cyclotides have been discovered in plants at peptide and DNA levels 
and many of them were characterised with a range of biological activities, including 
insecticidal, uterotonic, anti-HIV and cytotoxicity towards cancer cell lines as summarised in 
earlier sections [34]. The mode of action of cyclotides has always been an intriguing subject. 
On the basis of their broad range of activities, it has been believed that cyclotides exert 
biological activities through interactions with membranes. Understanding how cyclotides 
interact with biological cells will benefit rational drug design with reduced toxic effects. 
  
It is interesting to note that an individual cyclotide displays an array of activities. For 
example many cyclotides have shown to be cytotoxic to red blood cells and cancer cell lines 
[42]. The commonality of these activities suggests involvement of specific mechanism of 
action. Subsequently, biophysical studies with model membranes prove that cyclotides have 
an ability to target and disrupt biological membranes. Surface plasmon resonance studies 
suggest binding and insertion of cyclotides into lipid membranes [42, 43]. Furthermore, 
membrane leakage studies using fluorescence spectroscopy methodologies and 
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electrophysiological measurements support membrane disruption [44] induced by cyclotides. 
Transmission electron microscopy analysis of midgut epithelial cells of Helicoverpa 
punctigera larvae after the ingestion of kB1 evidences the severe membrane disruption, 
supporting insecticidal activity of kB1 [45]. 
 
The cell membrane in eukaryotic cells is fluid and rich in phospholipids containing 
phosphocholine (PC)-head groups, with smaller proportions of phospholipids containing 
phosphatidylethanolamine (PE), phosphatidylserine (PS) or phosphatidylinositol (PI) head 
groups. A systematic study conducted on individual and complex mixtures of model 
membranes showed that cyclotides bind to membranes by targeting specific lipid head 
groups. [42, 43]. All tested cyclotides showed higher affinity to membranes containing PE-
phospholipids, and lower affinity for PC, PS, PG, PI containing phospholipids [42]. 
 
 
Molecular level studies have been carried out to get more insights into the mode of action of 
cyclotides and have revealed the importance of hydrophobic and hydrophilic residues. NMR 
investigations using spin labels incorporated in dodecyl-phosphocholine (DPC) micelles 
showed that hydrophobic residues located on the surface of kB1 establish interactions with 
DPC [46]. Studies carried out by Shenkarev et al. [47] revealed the importance of 
hydrophobic residues in loops 5 and 6 of kB1 for affinity to membranes [47].  
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Figure 1.5 Representation of functional regions on molecular surface of kB1: hydrophobic 
(green), bioactive (blue region) and amendable face (light grey). 
 
A systematic Lys mutagenesis study was conducted to understand the functional role of 
positively charged and surface located residues [48]. In that study, Lys-residues were 
incorporated into hydrophobic (dark grey, Figure 1.5 A) or bioactive patches (black, Figure 
1.5 A) resulted loss of anthelmintic activity [48]. On the other hand, the substitution of Lys-
residues into the amendable face (light grey, Figure 1.5 B) led to an enhanced anthelmintic 
activity, which is thought to be due to electrostatic interactions between negatively charged 
head groups on the membrane surface and kB1. Overall from these studies, it has been 
speculated that kB1 exerts biological activity through two steps: 
 
Step 1:  Peptide insertion initiated by interaction between the hydrophobic patch 
located on the molecular surface of kB1 and the hydrophobic core of the 
biological membrane.  
Step 2:  The self-association of kB1 leads to pore formation. It should be noted that 
this speculation can only be applied to kB1 and kalata B2. 
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Through the many biophysical studies it has been concluded that the specificity towards the 
PE-head group containing phospholipids, hydrophilic and hydrophobic interactions play a 
crucial role in the interaction and targeting of biological membranes. However the kB1 is just 
one example and the fundamental mechanistic insights and the mode of action could be 
varied for different cyclotides. One of the objectives of this thesis to further expand 
knowledge on how different cyclotides interact with biological membrane using 
combinations of SPR, fluorescent measurements and cryo-TEM techniques. 
 
1.3 Aims and scope of this thesis  
As outlined in earlier sections, cyclotides are fascinating biomolecules with a unique set of 
characteristics and potential pharmaceutical applications. This PhD project aspired to make 
significant progress in the discovery and characterisation of novel cyclotides. The discovery 
of novel cyclotide-like sequences would allow us to better understand the biosynthesis and 
distribution of cyclotides in plants. The thesis focuses on two major goals: first, the discovery 
and characterisation of novel cyclotides; and second, the mode of action of cyclotides. The 
thesis is organised into six chapters as summarised in Figure 1.6.  
 
1.3.1  Discovery and characterisation of novel cyclotides 
Two naturally uncommon species belonging to the Violaceae family are Melicytus 
chathamicus and Melicytus latifolius. These species are endemic to remote islands of 
Australia, and were studied to confirm that cyclotides are probably ubiquitous within this 
family. A novel suite of Lys-rich cyclotides was discovered from M. latifolius with an 
unusual number of positively charged residues.  
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Figure 1.6: Schematic representation of the content of thesis, shows how the various chapters relate 
to one another. 
 
The discovery of novel Lys-rich cyclotides has driven my interest to further explore diverse 
plant families for the production of cyclotides: 206 plant species belonging to 46 families 
were studied for the presence of cyclotides. In total, 31 plant species belonging to the 
Rubiaceae and Violaceae were identified to possess cyclotides, as summarised in Chapters 3 
and 4.  
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1.3.2 Mode of action of novel cyclotides  
The membrane binding properties of selected cyclotides were evaluated using SPR binding 
studies against neutral phospholipids, including 1-palmitoyl-2-oleoylphosphatidylcholine 
(POPC) and 1-palmitoyl-2-oleoylphosphatidylethanolamine (POPE). Furthermore, 1-
palmitoyl-2-oleoylphosphatidic acid (POPA) and 1-palmitoyl-2-oleoylphosphatidylglycerol 
(POPG) were also included to examine the influence of negatively-charged phospholipids on 
the selected cyclotides. Regardless of sequence diversity, all the cyclotides tested showed 
significant binding to model membranes containing PE-phospholipids. These studies further 
support the hypothesis that cyclotides have specificity towards PE-phospholipids. A 
correlation between membrane binding affinity and cytotoxicity towards red blood cells, 
melanoma cancer cells (MM96L), fibroblast cells (HFF-1) and cervical cancer cells (HELA) 
was found. In addition to SPR experiments, I also studied membrane leakage using a 
fluorescence-based assay and cryo-TEM imaging in order to understand the membrane 
disruption mechanism of cyclotides.  
 
1.4  Significance of thesis 
One may ask why I am interested in cyclotides when there are many other macrocyclic 
peptides in nature (i.e. microbes, animals and plants). Macrocyclic peptides possess common 
characteristics, including head-to-tail cyclic backbone and structural motif. Cyclotides are 
equipped with a unique structural feature CCK formed by six cysteine residues on head-to-
tail cyclic backbone. In addition, many naturally isolated cyclotides display pharmaceutically 
important biological activities. The combination of their unique structural features and 
biological activities make cyclotides an attractive framework in peptide-based drug design. I 
started my thesis asking two major questions: to what extent are cyclotides distributed in 
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planta and how diverse they are?  And how do they interact with biological membranes? It 
should be noted that the field of cyclotides is young, yet ever growing.  
 
Discovery studies so far undertaken have revealed that plants belonging to the Violaceae 
family are rich sources of cyclotides; as a matter of fact every species screened from this 
family so far express cyclotides. It is quite intriguing to me why only in this plant family all 
the species possess cyclotides and in other plant families they are less common. My 
discovery of cyclotides endeavours started as a way to understand why every plant species of 
the Violaceae family express cyclotides. In previous studies, the search for cyclotides was 
conducted with Violaceae species grown on the mainland and widely available. In the current 
study, plants that are rare, threatened and have their habitat in remote islands of Australia and 
New Zealand were studied, specifically M. latifolius and M. chathamicus. Interestingly, an 
unusual set of Lys-rich cyclotides belonging to the Möbius subfamily was isolated in M. 
latifolius. Typically, Möbius cyclotides carry a net charge of zero whereas these Lys-rich 
peptides carry a net charge of + 5. Considering these novel features, I extended my studies to 
characterise their biological activities, mode of action and structure-activity relationship 
studies. The Lys-rich cyclotides were characterised for the first time in this thesis and are 
detailed in Chapter 3.  
 
The discovery of Lys-rich cyclotides clearly shows the diversity of cyclotides, which 
instigated the establishment of a large scale screening program. In previous years, only a few 
programs have been conducted for the discovery and characterisation of cyclotides. One 
example is the screening conducted by Dr Christian W. Gruber in which he carried out a 
large high-throughput screening of plant species aiming to understand the distribution of 
cyclotides. This work can be appreciated in his PhD thesis titled “Evolution, Biosynthesis and 
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Application of Circular Cystine Knot Mini-Proteins”. However, this screening was only 
confined to plant species belonging to the Rubiaceae family. Despite the fact that over 300 
cyclotides have been discovered in various plant families, their exact origin and distribution 
remains unclear. In my thesis, I aim to address this problem by investigating plant species 
that are from different families. Overall, 206 plant species from 46 plant families were 
included in my screening programme. Full length sequences of 50 cyclotides have been 
characterised from 31 plant species. The complete set of results from this discovery project 
are summarised in Chapter 4. 
 
As some of the novel sequences showed unusual features, my studies were extended to 
investigate their biological properties and mode of action. One of the intriguing questions is 
how exactly cyclotides interact with biological membranes. Previous studies have clearly 
demonstrated that cyclotides display biological activities through targeting and interacting 
with biological membranes. I wanted to confirm whether this feature is common for all 
cyclotides. In order to examine this hypothesis, ten novel cyclotides were tested on model 
membranes prepared from POPC, POPC/POPE (80:20), POPC/POPG (80:20) and 
POPC/POPE/POPG (80:20:20). From these results, strikingly it was found that the ability to 
bind membranes that contain PE-containing phospholipids is a common and well-conserved 
feature of cyclotides.  
 
Despite the ability to target PE-phospholipids, the efficiency to disrupt membrane varies 
across the cyclotide family. Furthermore, due to differences in their hydrophobic properties 
and overall charge I would like to propose that the disruption mechanism might be peptide-
dependent. In recent years, cryo-TEM has been used to study interactions between peptides 
and membranes. I planned to implement this technique to investigate the membrane 
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disruption mechanism of cyclotides. To determine how they disrupt membranes I selected 
four different cyclotides, kB1, CyO2, mela2 and mede_BM 4, each having varied sequence 
diversity. In summary, this thesis builds on a number of previous studies in the host 
laboratory and provides an extended understanding of the distribution of cyclotides among 
plants and their mechanism of action. 
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The objective of Chapter 2 is to provide details on the materials and methodologies used in 
this thesis. This background and explanations of the experiments conducted in this thesis will 
allow others to replicate and extend the studies. Additional specific methodologies for each 
project can be found in Chapters 3, 4 and 5. 
 
2.1 Plant collection 
A total of 206 plants belonging to 46 families was studied, with the plants selected based on 
several criteria: 1) plants used in traditional medicine; 2) plants belonging to Violacea or 
phylogenetically close families; and 3) plants from remote areas and/or with divergent 
geographical location. The initial discovery of the cyclotide kB1 happened while screening 
O. affinis, an African plant with uterotonic properties [1]. Inspired from this discovery, plants 
that are commonly used in Chinese traditional medicine were included as part of a screening 
program in this thesis. Plants belonging to the Violaceae family are regarded as a rich source 
of cyclotides, and indeed every species so far screened from this family has shown presence 
of cyclotides. Plants belonging to families phylogenetically close to the Violaceae, including 
Passifloraceae, Lamiaceae, Asteraceae and Fabaceae, were screened for the presence of 
cyclotides. In collaborating with other academic institutions and private botanic gardens, 
several plant species were obtained from divergent geographies. For instance, Leonia triadra 
and Gloespermum sphaerocarpum were obtained from the Columbian Amazon rain forest 
through collaboration with Professor Jaime Niño from Universidad Tecnológica de Pereira. 
Palicourea guianensis was collected from a private Australian rain forest garden located in 
northern Queensland. Rare plant species such as Melicytus latifolia and M. chathamicus, 
which are endemic to remote islands of Australia and New Zealand, were also examined in 
this study. These two plant species were collected in a field trip program at the Royal 
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Botanical Garden and the Blue Mountains Botanic Garden, Australia. The complete list of plant 
species studied in this thesis is provided in Appendix 1. 
 
2.2 Identification of plants with cyclotides 
The identification, isolation, purification and characterisation of cyclotides from the plant 
species studied in this thesis was carried out using combinations of LC-MS, RP-HPLC and 
tandem mass spectrometry. All the plant species were systematically analysed for the 
presence of cyclotides as illustrated in Figure 2.1.  
 
 
Figure 2.1 A schematic diagram illustrating the screening of selected plant species for the presence of 
cyclotides. 
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2.3 Small scale plant crude extraction 
Approximately, 1-2 g of dry/fresh plant materials was ground to powder in the presence of 
liquid N2 and extracted overnight with 5-10 ml of acetonitrile 50% (v/v) containing formic 
acid 2% (v/v). The extracts were lyophilized to evaporate solvent and stored at -20
o
C. The 
extracts were resuspended in ~100 μL of acetonitrile 10% (v/v) and analysed for the presence 
of cyclotides using a combination of LC-MS (Section 2.5) and MALDI-TOF (Section 2.6) 
techniques.  
 
2.4 Large scale plant crude extraction 
From the initial screening of small-scale extracts, plants identified with cyclotides were 
extracted at large scale as elsewhere described in the literature [2]. Dry/fresh plant material 
was ground to powder using a mortar and pestle by adding liquid N2 and extracted with 
dichloromethane (DCM) / methanol (1:1, (v / v)) overnight at room temperature. Debris from 
the extraction was removed by filtering through cotton wool/filter paper and transferred into a 
separating funnel. Adequate Milli-Q water was added until a clear separation was noticed 
between DCM and aqueous methanol layers. The top aqueous methanol layer was collected 
and the methanol was removed on a rotary evaporator followed by lyophilisation. All the 
lyophilised extracts were stored at -20
o
C for further analysis.  
 
2.5 LC-MS analysis of cyclotides 
The identification of cyclotides using LC-MS was carried out as described in previous studies 
[2]. The dry extracts were resuspended in 10% acetonitrile consisting 1% (v/v) trifluoroacetic 
acid and separated on a Phenomenex C18 RP-HPLC column (150 X 2.00 mm, 3 microns, 300 
Å) with a linear 1% min
-1
 acetonitrile gradient (0 to 80 % solvent B which consists 90% 
acetonitrile, 0.5% formic acid) at a flow rate of 0.3 mL min
-1
 on Schrimadzu LC-MS 2020. 
   Chapter 2 Materials and methods 
33 
 
The eluents were monitored on a dual wavelength UV detector set to 214 and 280 nm. The 
mass spectra of all LC samples were obtained in positive ion mode with a mass range of m/z 
400 – 2000 Da.  
 
2.6    MALDI-TOF analysis 
Molecular weights of all cyclotides characterised in this thesis were determined by matrix-
assisted laser desorption/ionisation time-of-flight mass spectrometry (MALDI-TOF-MS) on a 
4700 Proteomics Analyser (Applied Biosystems). The peptide samples were reconstituted in 
50% acetonitrile and diluted at 1:1 ratio with CHCA (α-cyano-4-hydroxycinnamic acid) matrix 
prepared at 5-6 mg/mL in 50% (v/v) acetonitrile and 2% (v/v) formic acid. One - two µL of 
peptide matrix mixture was spotted onto a stainless steel MALDI plate and dried in presence 
of liquid N2 or room temperature. The MALDI spectra of samples were acquired with the 
following conditions and spectra were analysed on Dataone explorer 4.1 software. 
Operating mode: Reflector positive mode 
Source voltage            : 20kV 
Mass range                 : 1000 – 4000 Da 
Focus mass                 : 3000 Da 
Laser shots                 : 1000 - 2000 
Laser intensity          : 2500 – 3500 
 
2.7    Purification of cyclotides  
Dried solvent extracts were suspended in approximately 20% (v/v) acetonitrile containing 2% 
(v/v) formic acid and separated on a Phenomenex C18 RP-HPLC column (250 X 21.00 mm, 
10 microns, 300 Å) with a flow rate of 8 mL min
-1
 at linear 1% min
-1
 acetonitrile gradient. 
Eluents were collected into individual test tubes of 10 mL capacity at 1-minute interval 
between 20 mins and 83 mins. All the fractions were analyzed for cyclotide like masses on 
Applied Biosystems 4700 as described above (Section 2.6). The factions containing cyclotide 
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like masses were pooled together and lyophilised. The lyophilised peptide samples were 
suspended in 20% (v/v) acetonitrile containing 2% (v/v) formic acid and separated on a 
Phenomenex C18 RP-HPLC column (250 X 10 mm, 5 microns, 300 Å) with a flow rate of 3 
mL min
-1
. The pure peptides were collected manually based on UV absorbance at 214 nm and 
280 nm. Purity of collected samples was analysed on MALDI-TOF-MS as described in 
Section 2.6. The pure cyclotides were freeze-dried and stored at -20
0
C for further studies 
including de novo characterisation, biological activities and mode of action studies.  
 
2.8     Reduction, alkylation and enzymatic digestion 
The reduction and alkylation of pure cyclotides was carried out as described in previous 
studies [2]. Approximately ~50 µM of lyophilised pure dry peptide was reconstituted with 40 
µL of 100 mM Na2HCO3 and mixed on vortex. The CCK motif of native cyclotides was 
unknotted by addition of 5 µL of 0.1 M DTT prepared in deionised water and incubated at 
37
o
C for one hour. The free thiol groups were capped with carboxymethyl amine by addition 
5 µL of 0.1 M iodoacetamide prepared in DIO and incubated at room temperature. Desalting 
of reduced and alkylated cyclotides was carried out using C18 Ziptips (Millipore). The 
modifications in reduced and alkylated cyclotides were analysed on MALDI-TOF-MS as 
described in Section 2.6. 
 
2.9 De novo sequencing of cyclotides 
The de novo sequencing of cyclotides was undertaken as described in previous studies [2]. 
The reduced and alkylated cyclotides were digested using individual proteolytic enzymes 
including endoGlu-C, trypsin and chymotrypsin or combinations of these enzymes. Each 
individual digest was performed by addition of 1 μL of 500 ng of enzyme to 10 μL of aliquot 
of reduced and alkylated cyclotide followed by incubation at 37
0
C for 3-4 hrs.  The digested 
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peptide samples were desalted using Ziptips (Millipore) followed by analysis on MALDI-TOF-
MS as described in section 2.6. 
 
The reduced and alkylated samples were subjected to MS/MS analysis using a Qstar Pulsar 
mass spectrometer (Applied Biosystems). Approximately, 5-7 μL of desalted peptide 
reconstituted in 80% acetonitrile 2% formic acid loaded into Proxeon nanospray tips and 
TOF-MS and MS/MS spectra were acquired applying the following conditions.  
 
Capillary voltage                           : 800 – 1000 Volts  
Collision energy                             : 10 – 50 Volts 
TOF MS spectra (m/z)                   : 500 – 2000 Da  
TOF MS/MS spectra (m/z)            : 100 – 2000 Da 
 
TOF-MS and MS/MS spectra were analysed on Analyst QS 1.1 Software. The de novo 
sequence was attained based on b-series and y-series ions.  
 
2.10     Quantification of lysines using acetylation 
The number of Lys-residues in the normal cyclotides was quantified based on acetylation 
experiments. Acetylation reagent was freshly prepared with 20 µL acetic anhydride and 60 
µL methanol. Approximately 15-20 μg of dry peptide was reconstituted in 20 µL of 50 mM 
ammonium bicarbonate. Acetylation reagent (50 µL) was added to 20µL of peptide solution 
and incubated at room temperature for one hour followed by lyophilisation to remove organic 
content. The samples were desalted using ziptips and the acetylation products were analysed 
on MALDI-TOF-MS) on a 4700 Proteomics Analyser (Applied Biosystems) as illustrated in 
above Section 2.5. Acetylation of peptides results in addition of acetyl group to free N-
termini or Lys-residues. Cyclotides feature a head-to-tail cyclic backbone, and hence they 
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lack free N-termini. The results of a mass increment of 42 Da to native cyclotide mass, 
suggests the presence of one Lys as described below.  
Cnative  = M (Da);   Cnative_acetylation  = M (Da) + 42 Da (one Lys-residue) 
 
2.11 Biological activities  
2.11.1  Haemolytic activities 
The cytotoxicity of cyclotides towards red blood cells was evaluated through a haemolytic 
assay as described in the literature [3]. Fresh red blood cells were prepared by adding several 
blood drops into eppendorf tubes filled with phosphate-buffered saline (PBS) (composed of 
1.5M NaCl, 30mM KCl, 80mM Na2HPO4 and 20mM KH2PO4) and gently mixed until 
homogenised. The blood samples were centrifuged at 4000 rpm and supernatant was removed 
carefully. The erythrocytes were repeatedly washed and made up to 0.5% (v/v) in PBS.  
 
Peptide stock solutions of 640 µM were prepared in PBS buffer and serially diluted in a 96- 
well round bottom plate obtaining a total of 12 concentrations. Melittin was used as a control 
peptide and prepared at the highest concentration of 80 µM. PBS, and 0.4 % Triton-X were 
used as negative and positive controls. The final concentrations of peptides (64 µM, 32, 16, 8, 
4, 2, 1, 0.5, 0.25, 0.125, 0.0625 and buffer) and red blood cells (RBCs) at 0.25% (v/v) were 
attained in mixing peptide and RBCs in a final volume of 120 µL. and incubated at 37
o
C for 
one hour. The plate was centrifuged at 1000 rpm and supernatant was transferred into a flat-
bottom plate. The absorbance of the supernatant was measured at 415 nm on a plate reader. 
The percentage of cells haemolysed was determined based on the following equation and the 
HC50 (peptide concentration required to lyse 50% of red blood cells) calculated in GraphPad 
Prism software. 
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Asample: absorbance of sample; Ablank: absorbance of blank; Atriton: absorbance of triton 
 
2.11.2  Cytotoxicity towards cancer cell lines 
The cytotoxicity of selected cyclotides towards melanoma cells (MM96L), cervical cancer 
cells (HeLa) and foreskin fibroblast cells (HFF-1) was evaluated based on resazurin dye 
assay as described before [4]. All selected cell lines were cultured with Dulbecco's Modified 
Eagle's medium (DMEM) containing 10% Fetal bovine serum (FBS) and incubated in T175 
flasks at 37
o
C at atmosphere of 5% CO2. The cells were seeded to 2.5x10
3
 cells per well in 
flat-bottom 96-well plates for 24 hrs before the experiments. Before starting the assay, the 
cells were washed with 100 µL of warm PBS and resuspended in 90 µL of fresh media. 
Peptide stock solutions were prepared at the highest concentration of 640 µM. The final 
peptide concentrations 64, 32, 1 6, 8, 4, 2, 1 and 0.5 µM were obtained by the addition of 10 
µL from stock solution and incubated for 2 hrs at 37
o
C in an atmosphere of 5% CO2.  
 
Asample: absorbance of sample; Ablank: absorbance of blank; Atriton: absorbance of triton 
The peptide solutions were removed and replaced with 100 µL of fresh media with serum. 
Freshly prepared 10 µL of resazurin dye (0.02 % w/v) and incubated for 18 hrs. Triton X-100 
(TX-100) (0.1 % v/v) was used as a positive control expecting 100 % cell death and sterile 
water as negative control. The absorbance was measured at 540 and 630 nm and the % cell 
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death was measured based on the above equation. The results were exported to GraphPad 
Prism to calculate CC50 (peptide concentration required for 50% of viability of cells) values.  
  
2.12 Membrane binding affinity of cyclotides 
In order to evaluate the lipid specificity, pure peptide solutions and various complex lipid 
mixtures were prepared to mimic the natural composition of biological membranes. The 
affinity of cyclotides towards biological membranes was evaluated on model membranes 
composed of synthetic lipids including POPC, POPG, POPA and POPE at different molar 
ratios. All the lipids were purchased from Avanti Polar Lipids, Inc. POPC was used as a 
major component of lipid mixtures as it maintains fluid properties at room temperature, 
which mimics the fluid phase of mammalian cell membranes. Large unilamellar vesicles 
(LUVs; 100 nm in diameter) were used for fluorescence measurements and cryo-TEM 
imaging, whereas small unilamellar vesicles (SUVs of 50 nm diameter) were used for SPR 
studies.  
 
2.12.1 Preparation of liposomes 
Stock solutions of phospholipids were prepared at concentration 10 mg/mL by dissolving 
individual phospholipid lipid powder in chloroform and stored at -20 
0
C. The required molar 
ratio of individual or mixture of phospholipid solutions was pipetted into a round bottom 
flask and chloroform was evaporated in the presence of liquid nitrogen and placed in a 
desiccator overnight. The dry lipid was hydrated in 10 mM HEPES buffer and 150 mM NaCl 
at pH 7.4, to mimic physiological pH and ionic strength. The lipid suspension was subjected 
to 6-8 freeze – thaw cycles to produce multilamellar vesicles (MLVs). The MLVs were 
extruded through 50 nm or 100 nm filter for 19 times to obtain SUVs or LUVs, respectively. 
For the SPR experiments, the liposomes were prepared at 2 mM. 
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2.12.2       Membrane binding affinity studies with SPR 
The affinities of cyclotides for model membranes was analysed. In recent years, SPR has 
emerged as a versatile label free technique to detect and quantify biomolecules that have 
specificity and affinity towards ligands. Biacore 3000 and L1 sensor chips (BIAcore, GE 
Healthcare) were used for cyclotide-membrane interaction studies [3]. L1 chip surface consist 
of a carboxymethylated dextran matrix with lipophilic alkyl groups that tend to bind to 
phospholipid head groups. As shown in Figure 2.2, the liposomes are captured onto sensor 
chip, which form a lipid bilayer and cyclotides of interest were injected onto the bilayer 
through flow cell. In principle, changes in refractive index are proportional to the amount of 
cyclotide bound to lipid bilayer on sensor chip.  
 
The peptide samples and lipid suspensions were freshly prepared in a buffer solution (10 mM 
HEPES and 150 mM NaCl at pH 7.4) filtered through 0.22 µm Millipore filter. The peptide 
solutions were prepared at different concentrations 2, 4, 6, 8, 10, 12, 14, 16, 32, 64 and 128 
µM. The L1 sensor chip initially was washed with running buffer (10 mM HEPES, 150 mM 
NaCl, pH 7.4) before injecting the lipid solution at flow rate (5 µL/min) into all flow 
channels (FC). The formation of stable lipid bilayer on chip surface was confirmed on the 
basis of a steady-state-plateau (Figure 2.3 A). The loosely bound lipid was removed by 
injecting sodium hydroxide at flow rate of 50 µL/min for 30 s followed by equilibrating with 
running buffer.  
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Figure 2.2 Diagram depicting the detection principle of surface plasmon resonance. The phenomenon of SPR 
occurs when light hits electrically conducting surface through prism, electrons in metal layer resonates termed 
plasmons. The reduction in reflecting light angle is proportional to mass accumulated on ligand surface, for 
instance. Figure adapted from Hoa et al., [5]. 
 
Peptide solutions were injected (association) at lowest (0) to highest concentration (128 µM) 
into flow channels for 180 s at a flow rate of 5 µL/min (Figure 2.3 B). The unbound peptides 
were dissociated from lipid bilayer by running buffer solution for 600s (Figure 2.3 B). All 
flow channels were regenerated for other peptide concentrations and subjected to a series of 
three washing steps:   
Step1: Initially flow channels were injected with 20 mM 3-[(3-
cholamidopropyl)dimethylammonio]-1-propanesulfonate (CHAPS) to remove 
the lipid bilayer from chip surface and stabilized by running buffer.  
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Figure 2.3 Evaluation of membrane binding affinities of cyclotides using SPR (A) Lipid bilayers of interest are 
deposited on chip surface and molar ratio of lipid was calculated after reaching equilibrium (B) peptide of 
interest injected onto the phospholipid bilayer for 180 s and molar ratio of peptide was evaluated (C) peptides at 
a range of concentrations were injected (D) and plotted as in function of peptide concentration. The binding 
efficiencies were evaluated on peptide to lipid (P/L) ratios.  
 
Step2: 10 mM sodium hydroxide in 20% v/v methanol at flow rate of 5 µL/min and 
stabilised with running buffer. 
Step3: Finally, all flow channels were washed with 10 mM sodium hydroxide at 50 
µL/min for 36 secs and stabilized with running buffer running buffer for 600s. 
Remaining concentrations were injected onto freshly deposited lipid bilayer 
(Figure 2.3 C) and washing steps were repeated.  
 
Association and dissociation rates and peptide-to-lipid (P/L) molar ratios were measured in 
order to compare the binding kinetics of cyclotides to different lipid system. The initial 
amount of lipid deposited on the chip in each flow cell was determined based on the response 
   Chapter 2 Materials and methods 
42 
 
units (RU) obtained in lipid deposition response curve. 1 RU is equivalent of ~1 pg/mm2 and 
the response units are converted into mol/mm
2
 of lipid deposited on the chip surface (Figure 
2.3 D). The response units from peptide bound were converted into mol/mm
2
.  The amount of 
peptide bound on lipid bilayer surface was calculated at 140 secs in association phase. P/L 
ratio was determined for each concentration of peptide and compared with the different lipid 
systems tested.  
    
2.12.3 Membrane permeabilisation properties of cyclotides 
The ability of cyclotides to permeabilise model membranes was evaluated using 
carboxyfluorescein (CF) dequenching as reported in previous studies [3]. For these 
experiments, LUVs with 12.5 mM of lipid concentration were prepared as described in 
Section 2.13. Initially, 50 mM of CF solution was prepared in HEPES buffer (pH 7.4) and 
used to hydrate LUVs. The non-entrapped CF molecules were removed through Sephadex G-
50 column. Vesicles that are larger than pore size will elute earlier, while small CF molecules 
get entrapped in the gel and elute later. The earlier fractions were collected into a 1mL 
eppendorf tube. The concentration of phospholipid was quantified based on Stewart assay as 
described below.  
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Figure 2.4 Evaluation of membrane permeabilisation properties of cyclotides: (A) LUVs prepared from 
individual and mixture of lipids as described in section 2.13 and loaded with self-quenched CF. The 
fluorescence was quantified from dequenching of CF after treatment with buffer, cyclotide of interest and triton. 
The permeabilisation abilities were calculated using the equation provided in section 2.3.5.  AHEPES = 
absorbance of HEPES buffer as blank, Asample = absorbance of after treatment with cyclotides Atriton = 
absorbance after treatment with triton X-100.   
 
2.12.4 Stewart assay: Quantification CF loaded vesicles 
The stewart assay is a colorimetric method used to quantify phospholipids, in which 
phospholipids form complex with ammonium ferrothiocyante. A stock of ammonium 
ferrothiocyanate reagent was prepared by dissolving 27.03 g of ferric chloride and 30.4 g of 
ammonium thiocyanate in 1 litre of distilled water followed by homogenisation with 
magnetic stirrer. A standard curve was prepared for each lipid mixture from known 
concentration of phospholipids with six different lipid concentrations including 12.5, 6.25, 
3.125, 1.5625, 0.781 mM and buffer. 10, 5, 2.5, 1.25, 0.5 μL of each concentration from 
stock solution and CF-loaded vesicles were pipetted into 15mL falcon tubes. The chloroform 
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was evaporated in the presence of gaseous nitrogen. To the dried phospholipid, 2mL of 
chloroform and 2mL of ammonium ferrothiocyante were added to each tube and processed 
through vortex homogenisation. The solutions were centrifuged at 4000 rpm for 5 mins to 
obtain clear sepearation of organic  and aqueous layers. The absorbance values for 
chloroform layers for each concentration was measured at λ=488 nm as shown in Figure 2.5 
A. The concentration of CF-loaded vescicles were evaluated based on the standard curve 
(Figure 2.5 B).  
 
Figure 2.5. (A) Absorbance of known phospholipid concentrations used to obtain (B) standard curve.  
 
 
2.12.5 Membrane leakage assay  
A stock solution of CF-loaded solution was prepared in HEPES buffer. Peptide stock 
solutions starting at 100 μM and serially diluted to obtain 100, 50, 25, 12.5, 6.25, 3.12, and 
1.56 μM. A total of 108 μL of 5.5 μM of CF-loaded vesicles were added to 96-well plates. 
Twelve μL of peptide solution was added to each well and incubated at 37oC for 20 minutes.  
The final concentrations of peptides solutions become 10, 5, 2.5, 1.25, 0.62, 0.312, or 0.156 
μM, whereas the final lipid concentration is 5 μM. Triton-X 100 (0.01% v/v) was used as 
positive control whereas the HEPES buffer solution is the negative control.  
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The fluorescence emission intensity of dequenched CF was measured with excitation at 490 
nm and emission at 515 nm. The percentage of leakage was determined for all peptide 
concentrations based on the above equation. LC50 (peptide concentration required to achieve 
50% of leakage) was calculated in GraphPad Prism by fitting the one-site specific binding 
with Hill slope equation.  
 
2.13 Cryo-TEM imaging of cyclotide-membrane interactions 
Large unilamellar vesicles (LUVs) composed of POPC/POPE (80:20) were used for cryo-
TEM imaging at the highest concentration of 13.68 mM (10 mg/mL) as described in Section 
2.13.  Peptides were prepared with 1.4 mM in HEPEs buffer. An aliquot of peptide and lipid 
mixture was prepared by transferring equal volumes of peptide and lipid samples into an 
eappendorf tube, reducing the concentration of peptide and lipid to one-tenth the initial 
concentration.  
 
Four µL of sample were transferred onto a lacey carbon grid, in an FEI Vitrobot Mark 3 (FEI 
Company, Eindhoven, The Netherlands), with the chamber set to 4ºC and 100% humidity. 
Optimal blot time was 4s or 5s, followed by plunging the sample/grid into liquid ethane. 
Frozen/vitrified samples were viewed on a Tecnai F30 FEG-TEM (FEI Company) operating 
at 300kV, and imaged 39,000x & 59,000x magnification with a Direct Electron LC1100 4k x 
4k camera (Direct Electron, San Diego, USA), using low-dose mode of SerialEM image 
acquisition software. Images were captured with a defocus of -2.0µm and a dose of 25 
electrons/Å
2
 [6]. 
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3.1 Abstract  
Hydrophobicity has been considered a key biophysical feature of cyclotides that has guided 
purification and has been used in the screening of novel cyclotides from plant extracts. 
Cyclotides are primarily categorized into two major subfamilies: bracelet and Möbius. In 
addition to the presence or absence of a cis-Pro in loop 5 they also differ in the number of 
charged residues. For instance, bracelet cyclotides typically carry a net charge of -1 to +1, 
whereas Möbius family members are normally globally neutral. In fact, bracelet cyclotides 
contain more charged residues compared to Möbius-type cyclotides. In the current study, a 
novel suite of Lys-rich cyclotides belonging to the Möbius subfamily were discovered from 
rare plant species M. latifolius and M. chathamicus that are distributed across remote islands 
of Australia and New Zealand. Unlike typical cyclotides, these Lys-rich peptides feature net 
charges of +4 to +5. The prime focus of this chapter is to describe the identification, isolation 
and de novo sequencing strategies of Lys-rich cyclotides. In order to understand the mode of 
action of these peptides, their biological activities, membrane binding and permeabilization 
properties were evaluated. Furthermore, structure activity relationship studies were also 
established using model structures. A manuscript has been published for this work and 
presented in this chapter. 
 
3.2 Methods 
The background and theory of methods/techniques used in this study are elaborated in 
Chapter 2 (Sections 2.1 to 2.10).  
 
3.3 Results and discussion 
It has been suggested that cyclotides are ubiquitous in the Violaceae family but not in other 
plant families. The Violaceae species so far examined have been from closely related 
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geographical regions or habitats. Here I focused on geographically isolated Violaceae species, 
including the threatened and uncommon species Melicytus chathamicus (Chatham Island, 
New Zealand) [1] and the rare and critically endangered species M. latifolius (Norfolk Island, 
Australia) [2]. The findings not only confirmed the presence of cyclotides in these isolated 
species but also revealed that these intriguing macrocyclic peptides are more diverse in 
sequence and biophysical properties than previously anticipated.  
 
3.3.1 Identification, purification and de novo sequencing of cyclotides 
In previous studies it has been observed that cyclotides typically elute between 45% and 60% 
acetonitrile during reversed-phase C18 HPLC separations [3]. Interestingly, I found five 
peptides from M. latifolius, specifically those with masses of 3159.3, 3093.3, 3105.3, 3171.3 
and 3063.3 Da, eluted relatively early during LC separations (Figure 3.1).  
 
 
Figure 3.1. HPLC profile of crude extract of M. latifolius 
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As illustrated in Chapter 1, cyclotides are a unique family of cysteine rich cyclic peptides 
featuring a set of properties, which have been used in the identification process. In the current 
study, the following features have been considered to confirm that identified peptides were 
cyclotides. 
      1.   Molecular mass range (2,800–3,500 Da).  
2. Three disulfide bridges formed by six cysteines. 
3. Head to tail cyclic backbones 
 
Figure 3.2. Charge state of cyclotides and quantification of Lys residues. a) ESI-MS spectra of Lys-rich 
cyclotide mela 2 (top panel) showing peaks corresponding to 2
+
 through to 5
+
 as a result of increased 
protonation at the additional basic residues and of mech 7 (bottom panel) showing peaks corresponding to the 
doubly- and triply-charged ion species commonly observed for cyclotides. b) Quantification of Lys through 
acetylation. MALDI-TOF-MS of mech 1 prior to acetylation (top panel) and following its acetylation with 
acetic anhydride (bottom panel) detailing the mass-shift observed.  
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In the consideration of above mentioned characteristics, cyclotides have been identified in M. 
latifolius and M. chathamicus. Interestingly, peptides in M. latifolius, exhibited charge states 
up to 5
+
 in electrospray ionization (ESI) MS analyses, suggesting the presence of a high 
number of protonation sites, typically associated with the basic residues His, Lys and/or Arg 
(Figure 3.2a, top panel), compared to conventional cyclotides (Figure 3.2a, lower panel).  
 
Multiple lines of evidence from studies employing acetylation (Figure 3.2b), tryptic cleavage 
and NMR (Appendix 1, Figure 3 & 5) confirmed the presence of four to five Lys residues in 
each of the characterized peptides and is explained in detail below. The presence of higher 
number of Lys residues explains the highly-charged ion species present in the ESI-MS 
spectra and their early elution properties in LC separation. Identical properties were found 
with peptides purified from M. chathamicus. Following purification of peptides from M. 
latifolius and M. chathamicus extracts using a combination of solid-phase extraction (C18) 
and HPLC, sequences of 14 peptides (Table 3.1) were determined via de novo sequencing. In 
accordance with the suggested standard nomenclature [4], the 14 novel peptides were named 
mech 1–7 and mela 1–7, from M. chathamicus and M. latifolius, respectively. 
 
De novo sequencing of cyclotides is not straightforward when compared to linear peptides. 
The presence of the CCK makes cyclotides topologically complex, and the absence of a free 
N-terminus hinders fragmentation in tandem MS analyses. In the present study the knotted 
topology was disrupted by reduction with dithiothreitol, and the subsequently free sulfhydryl 
groups were alkylated with iodoacetamide. The cyclic backbone was linearized using 
endoproteinase Glu-C (endoGlu-C), taking advantage of the highly conserved Glu residue in 
loop 1. The linearized forms of all new cyclotides were characterized by tandem MS 
sequencing. 
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The identification and sequencing of the novel cyclotides is exemplified in Appendix 1, 
Figure 1 for mela 2. Reduction and alkylation of mela 2 (3093.3 Da) resulted in a mass 
increase of 348 Da, indicating the presence of three disulfide bonds. The signal observed at 
3459.5 Da following endoGlu-C digestion indicated a further increment of 18 Da, consistent 
with cleavage of the peptide backbone and the presence of a single Glu (Appendix 1, Figure 
1a). The linear peptide obtained was subjected to nanospray MS/MS for de novo sequence 
determination. MS/MS fragmentation of linearized mela 2 revealed its sequence to be 
TCFKGKCYTPGCTCSYPLCKKDGKPTCGE (Appendix 1, Figure 1b). This sequence 
contains five Lys residues, which is unusual compared to the 0–2 positively charged residues 
of conventional cyclotides, but consistent with the decreased hydrophobicity of mela 2 
relative to previously reported cyclotides [5]. It should be noted that tandem MS alone is 
unable to distinguish the isobaric residues Lys/Gln and Ile/Leu. Thus, enzymatic digestion 
and side chain modification was used to distinguish these residues and unambiguously 
characterize the peptides.  
 
Reduced and alkylated mela 2 was further subjected to tryptic digestion, producing three 
major fragments with the sequences CYTPGCTCSYPLCK (1765.6 Da) (Appendix 1, Figure 
1c), KDGKPTCGETCFK (1526.5 Da) (Appendix 1, Figure 1d), and DGKPTCGETCFKGK 
(1583.7 Da). The combination of these fragments yielded the complete sequence of mela 2, 
which was consistent with the sequencing of the peptide observed following endoGlu-C 
digestion and confirmed the presence of four of the five Lys residues. The fifth Lys residue, 
in loop 6, was missed as it precedes a Pro which prevents trypsin enzymatic cleavage. To 
assign the remaining isobaric residues (Leu/Ile in loop 5 and Lys/Gln in loop 6), the ratio of 
these residues was determined using amino acid analysis (AAA). In mela 2, a single Ile/Leu 
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was shown by AAA to be a Leu (Appendix 1, Table 3). It should be noted that low levels of 
Arg and Ala were detected in this sample, presumably due to contamination by co-eluting 
peptides. The assignment of Leu/Ile in mech 2 and 3 and mela 6 and 7 were confirmed on the 
basis of TOCSY and NOESY NMR (Appendix 1, Figures 2 & 5). The positions of Leu/Ile in 
mech 4 were annotated on the basis of its homology to mra17a, which differs by the proto C-
terminal replacement of Asp with Asn in loop 6 and the Lys with Glu in loop 5 [6]. 
 
The precise number of Lys residues in the novel cyclotides was determined using acetylation, 
which results in the modification of the ε-amino termini of Lys side chains and free N-
termini. In contrast to linear peptides, the acetylation of cyclotides leads to the modification 
of Lys side chains only, resulting in a mass increase of 42 Da per Lys. Following the 
acetylation of mech 1 (3309.5 Da), a mass increase of 210 Da was observed, consistent with 
the modification of five Lys residues (Figure 3.2b). Furthermore, amino acid analysis of the 
isolated native peptides revealed amino acid ratios that were consistent with those obtained 
from de novo sequencing (AAA results for mela 2 are provided in Appendix 1, Table 3. 
 
The greater number of Lys residues explains the early elution times in HPLC of these new 
cyclotides relative to the typical late elution profile for cyclotides as well as the higher charge 
states observed in ESI-MS analyses [7]. Interestingly, all of the cyclotides characterized from 
M. latifolius belong to the Möbius subfamily, in which loops 2, 3 and 5 are highly conserved 
(Table 3.1). 
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Table 3.1.  Cyclotides identified in M. chathamicus and M. latifolius 
Peptide   Amino acid sequences Mass (Da)
a
 No of 
Lys 
Source Subfamily
b
 
mech 1 G-VIPCGESCVFIPCINKKK-CSCK-NKVCYRD
c 3309.54 5 M. chathamicus B 
mech 2 G-LPTCGETCTLGKCNTP--KCTCN-WPICYKD
d 3124.30  3 „‟ M 
mech 3 G-LPTCGETCTLGKCNTP--KCTCN-WPICYKN
d 3123.30 3 „‟ M 
mech 4 G-SIPCGESCVYIPCISSLLGCSCK-SKVCYKD
e 3217.41 3 „‟ B 
mech 5 G-VIPCGESCVFIPCISSVVGCTCK-NKVCYRD
f 3254.45 2 „‟ B 
mech 6 G-VIPCGESCVFIPCISSVVGCTCK-NKVCYRN
f 3253.47 2 „‟ B 
mech 7 G-IPICGETCTIGTCNTP--GCTCS-WPVCTRD
c 2963.18 0 „‟ M 
mela 1 G-KYTCGETCFKGKCYTP--GCTCS-YPICKKD
f 3159.31 5 M. latifolius M 
mela 2 G-KPTCGETCFKGKCYTP--GCTCS-YPLCKKD
d,f 3093.30 5 „‟ M 
mela 3 G-KPICGETCFKGKCYTP--GCTCS-YPICKKD
f 3105.33 5 „‟ M 
mela 4 G-KPICGETCFKGKCYTP--GCTCS-YPICKKN
f 3104.33 5 „‟ M 
mela 5 GSAIACGESCFKFKCYTP--GCSCS-YPICKKD
f 3171.31 4 „‟ M 
mela 6 G-LPTCGETCFKGKCYTP--GCSCS-YPICKKD
d,f 3064.27 4 „‟ M 
mela 7 G-LPTCGETCFKGKCYTP--GCSCS-YPICKKN
d,f 3063.29 4 „‟ M 
cyO 14
g
 GSIPACGESCFKGKCYTP--GCSCSKYPLCAKN 3177.34 4 V. odorata M 
Globa E GSAFGCGETCVKGKCNTP--GCVCS-WPVCKKN 3038.28 4 G. blakeanumh M 
Mass (Da)a
 
= experimental mass
 bM= Möbius subfamily B= bracelet subfamily cI/L was not determined. dI/L was 
determined on the basis of Amino Acid Analysis results and spin systems in NMR. eI/L was determined on the basis of 
homology to mram 17a which only differed by one residue in the position of Asp by Asn. fI/L was determined based on 
AAA ratios gcyO14: cycloviolacin O14 hGloeospermum blakeanum (Standl.) Hekking. The bold highlighted residues 
show the conserved pattern of loop sequences in Lys-rich cyclotides.  
 
3.3.2 Existence of identical cyclotides with Asp and Asn variation  
To date ~300 cyclotides have been characterized from plant species belong to different plant 
families. Very few cyclotides have been found identical apart from Asp and Asn variation 
[8]. In the current study, mech 2 and mech 3, mech 5 and mech 6, mela 3 and mela 4, mela 6 
and mela 7 were found as Asp and Asn variants. Having these results are in agreement with 
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recent study outcomes carried out be Poth et al., the Asp and Asn variants in this study were 
characterized as described in previous studies [8].  
 
The existence of an Asn or Asp in loop 6 of many of the novel cyclotides was unambiguously 
determined using de novo sequencing. However, some of the peptides provided equivocal 
mass spectral information, suggesting a mixture of isomers. The distinction between isomers 
containing Asn or Asp residues is demonstrated by the analysis of the otherwise identical 
peptides mech 2 and 3 (Appendix 1, Figure 4). The theoretical molecular weight, based on 
the reduced, alkylated and linearized full-length sequence of mech 2 is 3490.4 Da; however, 
the 
13
C isotope pattern does not match the calculated ratios. In the MS/MS spectrum of 
linearized mech 2, the y7 (GLPTCGE) and b21 ions reflect the expected theoretical 
13
C 
isotopic peak abundance. In contrast, the y8 (DGLPTCGE) and b22 ions had an ambiguous 
isotopic distribution. Taken together, the mass spectral evidence indicates the co-existence of 
peptides with Asp and Asn at the site of cyclization, a phenomenon previously described in 
C. ternatea [8]. On the basis of this evaluation, other Asn/Asp isoforms of cyclotides were 
ascribed (Table 3.1), suggesting that isomers of cyclotides containing Asn or Asp occurs, not 
only in plants from Fabaceae family (e.g. C. ternatea), but also in species from the Violaceae 
family.  
 
3.3.3 Bioinformatic analysis of novel cyclotides suggests a novel group: Lys-rich cyclotides 
As well as having a high number of Lys residues, the novel Möbius cyclotides isolated from 
M. latifolius maintain highly conserved loop sequences. In particular, there is significant 
homology in loops 2 (FKGK), 3 (YTPG) and 5 (SYPI), which differ over mela 1-7 only in 
two positions: mela 5 has a Phe in the third residue of loop 2 (FKFK), and mela 2 has a Leu 
in the last position of loop 5 (SYPL). Two known cyclotides, cycloviolacin O14 [9] and 
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globa E [10], possess high similarity to mela 1–7 (Table 3.1), with homology in loop 2 
(F/VKGK), loop 3 and the start of loop 6 (A/KN). These two peptides have more divergent 
sequences in loop 5 than mela 1–7, only sharing the first Ser residue and a Pro residue, but 
the similar arrangement of Lys residues and their total charges suggests that mela 1–7, 
cycloviolacin O14 and globa E should be classified as a novel subgroup within Möbius 
subfamily, namely, the Lys-rich cyclotides. The XKXK pattern in loop 2, a Pro in loop 5 
(characteristic of Möbius cyclotides), and a KKN [N/D] motif as the first residues of loop 6 
characterizes this subgroup of Möbius cyclotides. 
Table 3.2. Comparison of the charges of Möbius, bracelet, Lys-rich and trypsin inhibitor cyclotides. 
Class Count
a
 # negative charges
b
 # positive charges
c
 Total charge
d
 
  Median Mean Range Median Mean Range Median Mean Range 
Möbius           
Lys-rich
e
 9 2.0 1.6 [1,2] 4.0 4.4 [4,5] 3.0 2.9 [2,4] 
Lys-poor 85 1.0 1.6 [1,4] 1.0 1.3 [0,4] 0.0 -0.2 [-3,3] 
Bracelet 184 1.0 1.5 [0,5] 3.0 2.5 [0,7] 1.0 1.0 [-2,5] 
Trypsin 
inhibitor 
6 3.0 3.0 [3,3] 5.0 5.2 [4,6] 2.0 2.2 [1,3] 
a
Cyclotides in CyBase (www.cybase.org.au) were used to populate the table, excluding acyclotides, which do not have a 
cyclic backbone (see full list of cyclotides used in supporting information). 
b
All glutamate and aspartate residues are 
considered to be negatively charged. 
c
All lysine, arginine and histidine residues are considered to be positively charged. 
d
The total charge is the sum of positive and negative charge computed as in 
a
 and 
b
. 
e
Lys-rich Möbius cyclotides include 
mela 1–7, cycloviolacin O14 and globa E. 
 
The high Lys composition of this cyclotide subgroup is a striking feature that distinguishes its 
members from other Möbius and bracelet cyclotides (Table 3.2), but not from members of 
the trypsin inhibitor subfamily. The Lys-rich cyclotides have more positive charges (median 
of +4) than the bracelet (median of +3) or other Möbius (median of +1) cyclotides. The 
distribution of positive charges in the Lys-rich subgroup is also significantly different, with p-
values, computed using the Mann-Whitney-Wilcoxon test, of 3.5 x 10
-7
 relative to the 
bracelet family and 1.6 x 10
-9 
relative to the Lys-poor
 
Möbius cyclotides. In contrast to the 
Lys-rich cyclotides, which only have Lys amino acids as positively-charged residues, 
cyclotides not classified as Lys-rich display other positively-charged residues (i.e. Arg and/or 
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His) (Appendix 1, Table 4). For example, viba 14 has the highest number of positive charges, 
which are borne by six Arg residues and one His residue, whereas circulin D and E harbor 
three Lys and a single His [11]. The similar sequences and charge distributions of Lys-rich 
cyclotides suggest that they might have different biophysical properties, as well as biological 
functions to typical cyclotides; hence, we investigated their biological activities and mode of 
action through membrane affinity and leakage studies. 
 
3.3.4 Lys-rich cyclotides are able to bind and disrupt lipid membranes  
Cyclotides belonging to the Möbius or bracelet subfamilies display a broad spectrum of 
biological activities, including anticancer, anti-HIV, insecticidal and hemolytic activities 
[12], and these activities are reported to correlate with the ability of cyclotides to interact with 
lipid membranes [13]. This hypothesis is supported by studies carried out by Barbeta and 
colleagues, showing that the insecticidal activity of kB1 involves binding to and disruption of 
cell membranes in the midgut of Helicoverpa larvae [14]. Biophysical investigations also 
have provided compelling evidence to support the interaction of cyclotides with lipid 
membranes [13, 15]. Furthermore, NMR studies using dodecylphosphocholine (DPC) 
micelles, which mimic the hydrophobic environment in the membrane core, showed that the 
interactions of kB1 with micelles occurs with hydrophobic residues located on the surface of 
the molecule, suggesting that these residues might be important for insertion into the 
hydrophobic core of the lipid bilayer in biological membranes [16].   
 
To examine whether the novel Lys-rich cyclotides (mela 1–7) have bioactivities related to 
Möbius or bracelet cyclotides, we investigated their ability to interact with lipid bilayers. The 
membrane binding properties of mela 1, mela 2, mela 3 & 4 and mela 6 & 7 (mela 3 & 4 and 
mela 6 & 7 refer to mixtures of the Asn/Asp isoforms, not able to be separated by RP-HPLC) 
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were examined, along with mech 2 & 3 (typical Möbius cyclotides, but not Lys-rich) using 
SPR. For the sake of comparison, the prototypic Möbius cyclotide kB1 was also included. 
Phospholipids containing the zwitterionic phosphatidylcholine (PC) head group are the most 
abundant in eukaryotic cell membranes and POPC, which forms fluid bilayers at 25ºC, is 
commonly used to mimic the overall membrane fluidity and the neutral charge in the outer 
leaflet in eukaryotic cell membranes. Therefore, the membrane-binding affinity of the Lys-
rich cyclotides was initially tested with pure POPC. To discern the potential contribution of a 
specific phospholipid headgroup, mixtures of POPC with other phospholipids were also 
examined. 
 
The ability of the Lys-rich cyclotides to bind to membranes was dependent on the lipid 
composition (Figure 3.3a). Briefly, the Lys-rich cyclotides demonstrated very low binding 
affinity for neutral POPC bilayers, and to membranes with negatively-charged phospholipids, 
such as POPG or POPA (see POPC/POPG and POPC/POPA in Figure 3.3a). Conversely, the 
presence of POPE improved the affinity of all the Lys-rich cyclotides and of mech 2 & 3 to 
lipid bilayers, as shown with the mixture POPC/POPE. The ability to specifically bind to 
membranes containing phosphatidylethanolamine (PE)-phospholipids is a characteristic of all 
Möbius and bracelet cyclotides tested to date [17]. These results suggest that, despite the 
features distinguishing them from other cyclotides, Lys-rich cyclotides are similar to Möbius 
and bracelet cyclotides as they also require PE-phospholipids to efficiently bind to lipid 
membranes.  
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Figure 3.3 Membrane-binding potential of Lys-rich cyclotides. (A) Membrane-binding affinity of 
the novel cyclotides mech 2 and 3 and the Lys-rich cyclotides (mela 1–7) was evaluated using SPR 
against POPC, POPC/POPA (80:20), POPC/POPG (80:20), POPC/POPE (80:20) and 
POPC/POPG/POPE (60:20:20) bilayers. Peptide-to-lipid (P/L) ratios were calculated on the basis of 
the total amount of lipid deposited on the chip and to the total amount peptide bound to the lipid 
bilayer (1RU = 1 pg.mm
-2
) at the end of the peptide injection (t = 170 s). (B) Membrane leakage 
induced by the Lys-rich cyclotides against POPC/POPE (80:20) and POPC/POPG/POPE (60:20:20) 
vesicles. After 20-min incubation of peptides (0, 2, 4, 6, 8 and 10 μM) with lipid vesicles (5 μM), the 
percentage of membrane leakage was evaluated by measuring the fluorescence (λexcitation = 489 
nm/λemission = 515 nm). The data were fitted with a nonlinear regression using a sigmoidal binding with 
hill slope in Graphpad Prism Version 5.0d.  
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Table 3.3. Binding affinity and leakage of model membranes induced by selected cyclotides. 
  POPC/POPE (80:20)  POPC/POPE/POPG (60:20:20) 
Peptide P/Lmax
a
 KD (μM) LC50
b
 (μM) P/Lmax KD (μM) LC50 (μM) 
mela 1 0.15 ± 0.01 14.69 ± 1.23 >10 0.31 ± 0.01 08.14 ± 0.69 1.18 ± 0.28 
mela 2 0.20 ± 0.02 58.88 ± 13.51 >10 0.30± 0.02 12.28 ± 1.39 2.15 ± 0.42 
mela 3&4 0.30± 0.06 97.43 ± 40.19
c
 >10 0.32 ± 0.01 12.20± 1.14 1.51 ± 0.32 
mela 6&7 0.24 ± 0.02 28.69 ± 3.25 1.53 ± 0.12 0.33 ± 0.00 13.37 ± 0.20   0.6 ± 0.09 
mech 2&3 0.25 ± 0.01 33.62 ± 2.22 7.71 ± 0.28 0.35 ± 0.01 17.50 ± 0.72 8.93 ± 0.32 
kB1 0.19 ± 0.01 16.35 ± 1.11 4.44 ± 0.21 0.26 ± 0.00 19.79 ± 0.43 >10 
a
Membrane-binding dose-responses of cyclotides were studied by SPR (refer to Fig 3A) and the affinity compared 
with P/Lmax (the maximum binding response) and KD (concentration of peptide required to achieve half-maximum 
binding at equilibrium). KD and P/Lmax values were obtained by fitting dose-response curves with one-site specific 
binding with Hill slope. 
b
Concentration required to induce leakage in 50% of the vesicles. Total lipid concentration 
is 5 μM. c Difficult to establish the maximum response as the curve did not reach the plateau in the concentration 
range tested.  
 
The addition of negatively-charged POPG to POPC/POPE membranes substantially increased 
the binding affinity of the positively-charged Lys-rich peptides. Indeed, as shown in Table 
3.3 and Figure 3.3a, all the Lys-rich peptides have a KD of 8–14 M for binding to 
POPC/POPE/POPG (60:20:20 molar ratio) membranes, representing an improvement in 
affinity of 2- to 8-fold compared to binding to POPC/POPE mixtures. This increased affinity 
probably originates from an electrostatic attraction between positively-charged Lys residues 
of Lys-rich cyclotides and anionic phospholipids.  
 
Cyclotides are thought to exert their insecticidal and cytotoxic activities by permeabilizing 
membranes and we therefore investigated the ability of the Lys-rich cyclotides and mech 2 & 
3 to permeabilize model membranes. Membrane leakage studies were conducted using 
carboxyfluorescein-loaded large unilamellar vesicles (LUVs) composed of POPC, 
POPC/POPG (80:20), POPC/POPE (80:20), or POPC/POPE/POPG (60:20:20). In agreement 
with studies conducted with other Möbius or bracelet cyclotides [17], none of the tested 
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cyclotides cause leakage of the POPC or POPC/POPG vesicles but were able to permeabilize 
POPC/POPE vesicles. Interestingly, the incorporation of POPG lipids into the POPC/POPE 
vesicles increased the permeabilizing properties of the Lys-rich cyclotides (Figure 3.3b), but 
not of mech 2 & 3 or kB1 (Table 3.3 and Figure 3.3b).  
 
3.3.5 Correlation between membrane binding potential and biological activities  
We next tested whether the ability of the Lys-rich cyclotides to bind to lipid membranes 
translated to cytotoxic activity, and found the Lys-rich cyclotides do indeed show significant 
cytotoxicity towards cultured cells (MM96L, HFF-1 and HELA) but relatively low hemolytic 
activity (Table 3.4). When compared to healthy cells, the cell membrane of a cancer cell is 
more negatively charged, due to exposure of anionic phosphatidylserine-containing 
phospholipids, and possesses more PE-phospholipids exposed in outer leaflet [18,19]. The 
higher toxicity of the Lys-rich cyclotides against cultured cells versus red blood cells (Table 
3.4) correlated with enhanced membrane-binding affinity and permeabilization of the 
negatively-charged POPC/POPE/POPG compared to the zwitterionic POPC/POPE 
membranes (Table 3.3).  
 
Antibacterial peptides have been regarded as possible alternatives to antibiotics to overcome 
resistance to current therapeutics and are generally positively-charged peptides [20]. 
Although to date most cyclotides are relatively ineffective against bacterial cells, the high 
number of positively-charged residues in the Lys-rich cyclotides prompted us to evaluate 
their antibacterial properties. Mela 1, mela 2, mela 3&4, mela 6&7 and mech 1 were tested 
against Gram-negative (Escherichia coli) and Gram-positive (Staphylococcus aureus) 
bacteria by a microtiter broth method. But, despite their higher positive charge, none showed 
significant bacterial growth inhibition in the concentration range tested (up to 64 M). The 
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lack of activity against the tested bacteria suggests that regardless of their overall charge, 
cyclotides have weak efficiency as antimicrobials.  
 
Table 3.4. Cytotoxicity of selected cyclotides against cultured cells and fresh red 
blood cells (RBCs)
a
  
Peptide MM96L HFF-1 HELA RBCs  
mela 1  2.09 ± 0.18  3.07 ± 0.15  9.83 ± 0.78 >64 
mela 2  1.30 ± 0.44 5.86 ± 0.38 19.26 ± 1.37 >64 
mela 3&4  2.04 ± 0.26  5.39 ± 0.33 18.73 ± 1.82 ND
b
 
mela 6&7  1.58 ± 0.48  3.13 ± 0.16 11.42 ± 1.00 >64 
mech 2&3 21.94 ± 1.90 12.45 ± 0.99 36.92 ± 3.25 >64 
kB1   2.50 ± 0.50  7.43 ± 0.46 12.33 ± 0.72 27.58 ± 1.45 
a
The concentration required to kill 50% of cells (CC50 ± SD) is given in μM. CC50 and SD 
were determined by fitting dose-response curves with nonlinear regression equation with 
Hill slope. Dose-responses were conducted in triplicates. 
b
not determined, as the peptide 
was insufficient for the experiments.   
 
Although there is a high proportion of PE-phospholipids in the inner membranes of E. coli 
cells they are not surface-exposed as Gram-negative bacteria are covered with anionic 
(hydrophilic) lipopolysaccharide (LPS) [20]. As Lys-rich cyclotides do not bind to 
negatively-charged membranes, unless PE-phospholipids are present (see Figure 3.2a), the 
lack of activity against E. coli can be explained by the absence of surface-exposed PE-
phospholipids, which restrict cyclotides from targeting and inserting into the bacterial 
membrane. In S. aureus, the thick peptidoglycan layer is exposed on the surface, and the 
cytoplasmic membrane does not possess PE-phospholipids. Thus, despite the fact that some 
bacteria are rich in PE-containing phospholipids, in these cases they are not surface-exposed, 
and consequently the bacterial membranes are not targeted by cyclotides [17].  
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3.3.6 The role of hydrophobic and bioactive patches in determining biological activity and 
membrane binding potential  
 
Cyclotides belonging to the Möbius and bracelet subfamilies have been shown to have 
conserved bioactive and hydrophobic patches on their surface that are important for their 
ability to target PE-phospholipids and insert into the lipid membranes [15, 17]. The chemical 
shifts of mela 2 and mela 6 & 7 measured with TOCSY and NOESY NMR spectra (see 
spectra in Appendix 1, Figures 3 and 5) are similar to that of, the prototypic Möbius kB1 
(Figure 3.4a) and of the Lys-rich cyO14 (Appendix 1, Figure 6a) suggesting they have 
similar three-dimensional structures. Modeling studies of the Lys-rich cyclotides (Figure 
3.4b and Appendix 1, Figure 6b) based on chemical shifts indicate that they also display 
bioactive and hydrophobic patches on their surface, suggesting a similar membrane-binding 
mode. A previous binding study using kB1 and DPC micelles, monitored by NMR 
spectroscopy, suggested that the hydrophobic patch inserts into the hydrophobic core of the 
membrane [21], and another study suggested that the bioactive patch, especially the 
conserved Glu 7, is involved in targeting PE lipids [17]. Based on the structural homology 
with kB1, the surface-exposed residues assumed to be involved in the membrane binding are 
indicated in Figure 3.3b. Interestingly, Lys-11 and Lys-13, present in mela 1–7, are located 
between the hydrophobic and the bioactive patches and are likely to promote extra 
interactions with anionic lipids.  
 
The results from this study further support the notion that, although the presence of PE-
phospholipids is a requirement for cyclotides to bind to the membrane, the overall 
hydrophobicity, net charge and location of the charges [15, 17, 22] are important for the 
overall membrane-binding affinity. For instance, mela 6&7, a peptide with a net charge +2, 
displays higher membrane binding affinity and ability to disrupt neutral POPC/POPE model 
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membranes (see Figure 3.3 and Table 3.3) than the other Lys-rich cyclotides with net charge 
of +3 (e.g. mela 1-4), probably because mela 6&7 is the most hydrophobic peptide in this 
series (see crude extract RP-HPLC profile in Figure 3.1).  
 
 
Figure 3.4. NMR and modeling studies of the Lys-rich cyclotides. (A) The overlay of relative cross peaks 
(for all residues except H
N
-Hα and Hδ
2
-Hδ
3
 of Pro) of kB1 with mela 2 and mela 6 &7. (B) The structural 
models of mela 1, mela 2, mela 3 & 4 and mela 6 & 7 based on the structure of kB1 (PDB: 1NB1).   
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All the Lys-rich peptides showed higher affinity to bind to and disrupt the anionic 
POPC/POPG/POPE membranes, than the neutral POPC/POPE membranes, but differences in 
the binding affinity for POPC/POPG/POPE are smaller between mela 6&7 and other Lys-rich 
cyclotides, probably because the extra Lys charge in mela 1-4 promotes extra interactions 
with anionic lipids and therefore the larger hydrophobicity of mela 6&7 is off-set by its lower 
overall charge. A previous study showed that the substitution of Lys residues in the so-called 
amendable face of kB1 (Gly-18, Thr-20, Ser-22, Thr-27, Asn-29 and Gly-1) resulted in 
enhanced hemolytic activity [23]. In agreement with this result, none of the Lys-rich peptides 
have Lys residues in the positions corresponding to the amendable face of kB1, and the Lys-
rich peptides have lower hemolytic activity than kB1.  
 
It is worth noting that the classification of these novel Lys-rich cyclotides as part of the 
Möbius subfamily is supported by their identical specificity for PE-phospholipids and 
tridimensional structure to kB1, the prototypic Möbius, and their separation into a subgroup 
is based on their distinct primary sequence characterized by the presence of the XKXK 
pattern in loop 2, a Pro in loop 5 (characteristic of Möbius cyclotides), and a KKN [N/D] 
motif as the first residues of loop 6. 
 
3.4 Conclusions 
Here we have reported the discovery of a novel suite of Lys-rich cyclotides from 
geographically isolated parts of Australasia, confirming that cyclotides are a diverse and large 
family of naturally occurring macrocyclic peptides, and supporting the hypothesis that they 
are ubiquitous among Violaceae. Despite their origin from varied geographies and their 
sequence diversity, the cyclotide framework exhibits a conserved structure and membrane-
binding specificity. Conventionally, cyclotides have been thought to be mainly hydrophobic 
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and thus the discovery of Lys-rich cyclotides potentially opens the door for the search of new 
biophysical properties of cyclotides. The identification of uniformly hydrophilic cyclotides in 
M. latifolius suggests that their function in planta might be unique, or that the common 
function of cyclotides in plants is not modulated solely by their hydrophobicity.  
 
The discovery of Lys-rich cyclotides provides new insights into the structure/activity 
relationships of cyclotides, adding to our understanding of cyclotide modulation through 
modifications of the hydrophobic and bioactive patches. Hemolytic activity is one of the 
hallmark bioactivities of cyclotides, but is undesirable from a drug design perspective. Given 
the lower hemolytic activities of the Lys-rich cyclotides they might have potential in drug 
design. Furthermore, the possibility to specifically target membranes of cancerous cells, 
which display anionic lipids on their surface, could be exploited to design new cyclotide 
based anti-cancer drugs.  
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4.1       Abstract 
Cyclotides have been found in species from the Violaceae, Rubiaceae, Cucurbitaceae, 
Fabaceae and Solanaceae families; however, their broader occurrence and distribution within 
the plant kingdom is unclear. Interestingly, every plant species screened so far from the 
Violaceae family showed the presence of cyclotides, suggesting ubiquity among this plant 
family. The discovery of Lys-rich cyclotides (Chapter 3) from rare plant species belonging 
to this family group fuelled my further interest to explore more plant species. In my screening 
studies some of the plants were selected based on their applications in traditional medicine, 
and others were included to include a diversity in distribution and habitats (Appendix 1, 
Table 2). The hypothesis that the Violaceae family is a rich source of cyclotides was further 
supported by this screening program, as all the plants species belonging to Violaceae were 
shown to express cyclotides. On the other hand, despite Rubiaceae and Fabaceae are the 
largest plant families, only two out of 10 species screened belonging to Rubiaceae and none 
of 85 belonging to the Fabaceae family showed the presence of cyclotides. Cyclotides are 
fascinating molecules with significant sequence diversity and individual peptides are seldom 
repeated in multiple plant species. Interestingly, 18 out of the 204 plant species screened in 
this study were identified to possess kalata S and cycloviolacin O12.   
 
Over 300 cyclotides have been discovered to date from plant families Violaceae, Rubiaceae, 
Cucurbitaceae, Fabaceae and Solanaceae. Few sets of cyclotides, for instance, kalata B1 and 
B4, kalata B6 and B10, cycloviolacin O8 and O19, and cycloviolacin O3 and O20, Cter B 
and C; Cter D and E; Cter G and H; Cter I and J; and Cter K and L with only Asp and Asn 
variation in loop 6. Peptides and proteins are usually susceptible to a variety of chemical 
modifications both in vitro and in vivo, which may influence their structure and biological 
functions. Furthermore, analysis of ESTs from O. affinis and proteomic analysis of fresh 
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plant material further warrent the variation of Asp and Asn in plants.  
 
In this study, a series of cyclotides have been identified with Asp and Asn variation. It was 
initially thought to be a natural phenomenon occurring in plants themselves. However, 
careful mass spectrometry analysis revealed deamidation of Asn to Asp. These results are 
consistent with literature suggesting that peptides could undergo deamidation upon subjection 
to external factors including pH, temperature and enzymatic digestion. A detailed further 
explantation is given the following sections of this Chapter.  
 
4.2 Materials and methodologies 
The background and theory of methods/techniques used in this study are elaborated in 
Chapter 2 (Section 2.1.1 to 2.1.9).  
 
4.3 Results 
4.3.1 High-throughput screening and identification of cyclotides 
Plants are the warehouse of various classes of secondary metabolites and require rigorous 
analysis to characterise them. As elsewhere described in this thesis, cyclotides are a major 
family of plant derived macrocyclic peptides and can be identified based on their unique 
biophysical properties:  
1. Hydrophobicity: late eluent profile in HPLC separation (Figure 4.1 D) 
2. Mass range of between 2500- 3500 Da (Figure 4.1 E) 
3. Cyclic cystine knot (CCK) on head-to-tail cyclic backbone (Figure 4.3 A) 
 
The identification of cyclotides among the selected plants species (Appendix 1, Table 1) was 
achieved by using combinations of abovementioned characteristic features. For example, as 
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shown in HPLC chromatogram (Figure 4.1 D), the circled late eluents are more hydrophobic 
than the remaining eluents. The MALDI-TOF mass spectrometric profile of this extract 
revealed that the circled eluents are in the mass range of 2500-3500 Da (Figure 4.1 E) 
provided compelling evidence for the presence of cyclotide-like peptides in the selected plant 
species. In following that, 29 plant species were identified with cyclotides (Figure 4.2) and 
these were isolated and purified using HPLC for de novo sequencing using tandem mass 
spectrometry.   
 
Figure 4.1: High-throughput screening of selected plant species for presence of cyclotides. (A) All 204 
plant species were collected from different regions around the globe and (B) ground to powder using mortar and 
pestle followed by (C) extraction with 60% (v/v) acetonitrile with 2% (v/v) formic acid. The extracts were 
analysed on (D) Shimadzu LC-MS 2020 for eluent profile and (E) Applied Biosystems 4700 MALDI-TOF 
system for mass range.  
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Figure 4.2: List of plant species screened for the presence of cyclotides. A total of 204 plant species 
(Appendix 1 Table 1) belonging to 46 different families was screened. All the plant species were screened using 
high-throughput method established using HPLC-MS, LC and MALDI-MS. Twenty nine plant species 
belonging to the Violaceae (27 species) and Rubiaceae (2 species) families were identified with cyclotides. 
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4.3.2 De novo sequencing 
De novo sequencing of cyclotides is not straightforward due to: (1) lack of free N-termini; (2) 
the presence of the CCK preventing fragmentation in tandem mass spectrometry; and (3) 
multiple chemical modifications. However, years of characterisation of cyclotides in Craik‟s 
laboratory has allowed the establishment of an optimised protocol that include the following 
steps: 
 
Step 1: ~ 100 µg of 90 - 95% pure cyclotide extracted from plant.  
Step 2:  Unknot CCK by treating the peptide with DTT (or any other reducing agent) 
and alkylate with iodoacetamide to cap free thiol groups followed by 
analysing modifications on Applied Biosystems 4700 MALDI-TOF. 
Step 3: Taking advantage of the conserved Glu in loop 1 of cyclotides, treat reduced 
and alkylated peptides with endoproteinase-Glu-C which will result in linear 
products.  
Step4: Subject the linear product(s) to nanospray ESI-MS/MS to obtain the 
fragmentation in a series of b-ions and y-ions.  
Step 5: Deduce the de novo sequence of novel cyclotides based on b-ions and y-ions 
using Analyst QS 1.5 software.  
 
De novo sequencing of cyclotides is illustrated using data from mede_VC 1. The native mede 
VC 1 (2937.2 Da, [M+H]
+
) was reduced with DTT to unknot CCK followed by alkylation 
with iodoacetamide to cap the free thiol groups. As a result, an increment of 348 Da (2937.2 
Da + 348 Da = 3285.2 Da) to native molecular mass was observed, which is equivalent to six 
cysteines (Figure 4.3A).   
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Figure 4.3 De novo sequencing of mede_VC 1. (A) the MALDI-TOF-MS of mede_VC 1 after reduction, 
alkylation with increment of 348 Da followed by endo-Glu-C digestion resulted increment of 18 Da leading to a 
linear product 3304.3 Da. (B) MALDI-TOF-MS of reduced, alkylated and linearized product of mede_VC 1 (C) 
The linear precursor was subjected to nanospray-MS/MS. Data were collected on 1102.4 [M+3H]
+
 precursor as 
illustrated in Figure 4.4.  
 
The reduced and alkylated mede_VC 1 was treated with endoGlu-C to linearise the cyclic 
backbone, which resulted in a further increment of 18 Da (2937.2 Da + 348 Da + 18 Da = 
3303.3 Da) (Figure 4.3A). The linear product was subjected to ESI-MS and resulted in a 
triply charged precursor (1102.2, m/z) selected as precursor ion (Figure 4.3B) for MS/MS 
fragmentation. On the basis of y- series (y2-y16) and b-series (b2-b16) ions, the complete 
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sequence of mede_VC 1 was deduced as TCTLGTCNTPGCTCSWPICTKDGIPTCGE 
(Figure 4.4).  
 
Figure 4.4: Sequence of mede_VC 1. The linear precursor was subjected to nanospray-MS/MS. The data were 
collected on 1102.1 [M+3H]
+
 precursor. The obtained data were processed and analysed on Analyst QS 1.5 
software. Following the identification of b-ions and y-ions, the complete sequence was deduced as described 
previously [2]. 
 
One of the typical problems in tandem mass spectrometry is differentiating isobaric residues 
including Gln/Lys and Ile/Leu, but these can be differentiated by combining tryptic digestion, 
chymotryptic digestion and acetylation. For instance, full-length sequence data for mede_VC 
1 obtained from endoGlu-C digestion shows the presence of one Gln/Lys. Acetic anhydride is 
an acetylating agent which reacts with free amines by adding anhydrate group equivalent to 
42 Da [1].  
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M
1
:Möbius B
2
:bracelet hybrid specie
3
:Plant species provided in Table 1 (Appendix 1) from 186 to 200 are 
hybrid varieties which have been named after their local names.  
 
Table 4.1. Novel cyclotides identified in the current study 
Peptide Peptide sequence Mass(Da) Plant name Subfamily 
letr 1 GV--ACGESCVYIPCFTV-—GCTCTSS-QCFKN 2882.1 L. triandra 
 
 
 
   B1 
glsp 1 GVI-PCGESCVFIPCISAVIGCSCKNK-VCYRN 3237.5 G. sphaerocarpum B 
glsp 2 GVI-PCGESCVFIPCISTVIGCSCKNK-VCYRN 3267.5 G. sphaerocarpum B 
glsp 3 GVI-PCGESCVFIPCISAAIGCSCKNK-VCYRN 3209.4 G. sphaerocarpum 
L. triandra 
B 
lsp 4 GI--PCGESCVFIPCVSSIVGCSCKNK-VCYRN 3140.3 G. sphaerocarpum B 
pagu 1 GSI-PCGESCVFIPCISGLAGCSCKNR-VCYLD 3169.4 P. guianensis B 
pagu 2 GVI-PCGESCVFIPCISVKK-CSCKNK-VCYRN                                                                                                                         3252.5 ‘’ B 
vipu 1 GVI-PCGESCVFIPCISAVIGCSCKSK-VCYRN 3210.5 V. pubescens B 
vipu 2 GII-PCGESCVFIPCISSVIGCSCKSK-VCYKN 3212.4 ‘’ B 
vipu 3 GII-PCGESCVFIPCISTIVGCSCKSK-VCYKN 3226.4 ‘’ B 
hyfl I GI--PCGESCVFIPCISGVIGCSCKSK-VCYRN 3097.4 ‘’ B 
mede_BM 1  GIP-ICGETCFFGKCNTPK—-CTCINP-ICYKN 3142.3 M. dentatus_BM M2 
mede_BM 2 GI--PCAESCVYIPCISGVIGCSCKNK-VCYRN 3154.4 ‘’ B 
mede_BM 3 GTI-PCGESCVYIPCITSAIGCSCKNK-VCYRN 3257.4 ‘’ B 
mede_BM 4 GIP-ICGETCFFGKCNTPK--CTCNKP-ICYKN 3157.4 ‘’ M 
mede_BM 5 GVT-PCGESCVYIPCISSVIGCACKSK-VCYKN 3186.4 ‘’ B 
mede_BM 6 GSI-PCGESCVWIPCISSVVGCACKNK-VCYKN 3222.4 ‘’ B 
mede_BM 7 GKP-ICGETCFKGKCYTP--GCTCSYP-VCKKN 3090.3 ‘’ M 
cter P GI--PCGESCVFIPCITAAIGCSCKSK-VCYRN 3097.3  ‘’ B 
mede_BM 8 GI--PCGESCVYIPCITTAIGCSCKNK-VCYRN 3170.4 ‘’ B 
mede_BM 9 GSI-PCGESCVYIPCISAVIGCSCKNK-VCYRN 3241.4 ‘’ B 
meob 1 GFP-TCGETCTLGTCNTPG—-CTCSWP-ICTRD 2999.1 M. obovatus M 
meob 2 GFP-TCGETCTLGTCNTPG-—CTCSWP-ICTRN 2998.1  M. obovatus & 
M. angustifolius 
M 
meob 3 GIP--CGESCVYIPCITAAIGCSCKSK-VCYRN 3113.3 ‘’ B 
meob 4 GKP-ICGETCAKGKCYTPK--CTCNWP-ICYKN 3184.3  M. obovatus M 
kalata S GLP-VCGETCVGGTCNTP--GCSCSWP-VCTRN 2876.1 
V.  nagasawae, 
V.  inconspicua, 
V.  arcuata and 
hybrid species
3
 
M 
CyO12 GLP ICGETCVGGTCNTP--GCSCSWP-VCTRN 2890.1 ‘’ M 
vina 1 GSIPACGESCFKGKCYTP--GCTCSKYPLCAKN 3191.3 V.  nagasawae B 
vitr 1 GIPV-CGETCTIGTCYTA—-GCSCSWP-VCTRN 2957.1 V.  inconspicua M 
vidi 1 GIP--CGESCVFIPCISSVVGCSCKSK-VCYRN 3113.3 V. diffusa B 
mede_VC 1 GIPT CGETCTLGTCNTP--GCTCSWP-ICTKN 2936.1 M. obovatus 
M. dentatus_VC 
M 
mede_VC 2 GSIP-CGESCVYIPCISSVIGCACKSK-VCYKN 3187.4 M. dentatus_VC B 
mede_VC 3 GSIP-CGESCVWIPCISSVVGCACKNK-VCYKN 3223.4 ‘’ B 
mede_VC 4 GTIP-CGESCVYIPCITVVSGCSCKNK-VCYKN 3244.4 ‘’ B 
mede_VC 5 GIPI-CGETCFTGKCYTP--GCTCSYP-ICKKN 3063.2 ‘’ M 
mede_VC 6 GFSFVCGETCVIGKCYTP--GCTCNRP-NCKKN 3205.3 ‘’ M 
4 2 
3 
Loop 5 
Loop 6 
1 
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Acetylation of native mede_VC 1 resulted in an increment of 42 Da, suggesting the presence 
of only one Lys and this is further confirmed by tryptic digestion. Interestingly, some 
cyclotides, including pagu 2 and mede_BM 7, have an unusually high number of Lys 
residues (i.e., 4 to 5 Lys residues), which were confirmed on the basis of acetylation. 
Considering the sequence similarity, mede_BM 7 is considered as Lys-rich cyclotide 
(Chapter 3). De novo sequencing of letr 1 suggests the presence of two Gln/Lys. However, 
acetylation of native letr 1(2883.2 Da) resulted in an increment of 42 Da (2925.0 Da) 
suggesting the presence of only one Lys. The position of the Lys was further confirmed by 
tryptic digestion, as trypsin possesses high specificity at the C-terminus of Lys. By following 
this strategy, a total of 36 cyclotides (4 known and 32 novel) was characterised in this study 
and their full-length sequences are provided in Table 4.1. However cyclotides have been 
identified in plants Viola riviniana and Hedyotis centranthoides, they were not characterized 
due to insufficient amount peptide.  
 
4.4      Discussion  
The objective of the current study was to understand the distribution and sequence diversity 
of cyclotides among planta. To achieve this, 204 plant species belonging to 46 plant families 
were studied as presented in Table 1 (Appendix 1). Among the studied plants several are 
used in traditional Chinese medicine. Fabaceae is the third largest plant family, representing 
around 27% of total crop production consumed worldwide and also includes many plants 
with pharmaceutical significance [3]. To date Clitoria ternatea is the only species from 
Fabaceae found with cyclotides; therefore, a number of other Fabaceae species was included 
to screen for the presence of cyclotides (Appendix 1 Table 1). To understand and compare 
cyclotide diversity between wild species and hybrid varieties within single plant family, 15 
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hybrid species of Violaceae family plants were analysed. Here I report 36 novel sequences of 
cyclotides from 29 different species characterised using tandem mass spectrometry.  
 
4.4.1 Analysis of novel cyclotide sequences 
The novel cyclotides have the highly conserved CCK motif formed by six intra cysteines, and 
each loop has significant sequence diversity. Comparison of the sequences in each loop 
reveals that loop 1 is highly conserved with three residues consisting of Gly in first position, 
Glu in second position and the third residue varies with Thr/Ser/Ala. Loop 2 in bracelet 
cyclotides possess VXIP (X=F/Y/W) whereas Möbius cyclotides showed higher diversity 
with AKGK, FKGK, FFGK, TLGT, FTGK or VIGK (Table 4.1). Loop 3 of Möbius 
members is highly conserved with four residues XTPG (X= N/Y), whereas bracelet members 
show higher diversity with to six residues. Loop 4 of both Möbius and bracelet is the smallest 
with only one residue usually Thr, Ser or Ala.   
The classification of cyclotides into subfamilies is mainly based on the presence or absence 
of a cis-Pro in loop 5. In the current study, most of the bracelet and Möbius members were 
clearly identified without any ambiguity except letr 1. Loop 5 of letr 1 possesses TSSQ, 
which is not typical of either bracelet or Möbius cyclotides. Nevertheless, loop 2 of letr 1 is 
VYIP, a highly conserved motif of bracelet family members, suggesting its inclusion in the 
bracelet subfamily. Loop 6 has the highly conserved Asp or Asn proceeded by Gly at C-
termini, thought to be involved in the cyclisation event. Compared to previously identified 
cyclotide sequences, loop 6 in the novel cyclotides sequences is more diverse and includes 
FKDGVA (L. triandra), KKD(/N)GKPI, TKDGLIPT, KKD(N)GFPT and KKDGFSF. These 
diverse and significant interchangeable residues present in loop 6 suggest that cyclotides are a 
naturally occurring combinatorial library of peptides.   
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Möbius cyclotides usually carry a net charge of 0 whereas bracelet members carry -1 to +2 
(www.cybase.org.au). Interestingly, the net charge of mede_BM 7 is +5, which is unusual 
compared to other typical Möbius cyclotides. Most of the cyclotides characterised from M. 
dentatus (Blue Mountains origin) were found eluting between 35-50 min in LC purification, 
although mede_BM 7 eluted at 30 min. The high charge state and earlier retention times 
could be due to the presence of high protonation sites, including Lys residues.  
4.4.2 Are Asp and Asn isoforms real or artefacts in mass spectrometry? 
The presence of an Asp or Asn in loop 6 is a highly conserved feature in cyclotides and is 
known to be pivotal in the cyclisation event. In fact, all the novel cyclotides characterised in 
this study also possess an Asp or Asn. However, distinguishing the presence of Asp vs Asn in 
cyclotides was very challenging as the mass spectrometric data suggest that most of the 
cyclotides in this study exist in mixtures of Asp and Asn isoforms.  
 
Most of the residues in the novel cyclotides were unambiguously distinguished. However, the 
fragmentation of most cyclotides generated ions with equivocal isotopic distribution, 
suggesting possible presence of Asp and Asn isoform mixtures. For example, the theoretical 
mass of meob 1 corresponds to 3304.3 Da [M+H]
+
 after reduction, alkylation and 
linearisation (Figure 4.5). As can be seen in Figure 4.5, the C13 isotopic distribution is 
mismatched, and with 1 Da lower than the expected theoretical mass suggests presence of 
Asp and Asn isoforms. The isotopic distribution of b21 and y7 were clear as expected, 
whereas the subsequent ions were skewed with 1 Da lower than the theoretical C13 isotopic 
distribution. For instance, in the b-series b22 ion at m/z 1286.5
2+ 
corresponds to 
TCTLGTCNTPGCTCSWPICTKD whereas 1286.02+ corresponds to Asn at the C-termini. 
Similarly, y8 ion at m/z 848.3 corresponds to DGIPTCGE, whereas m/z 847.3 corresponds to 
an occurrence of Asn at C-termini. 
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Figure 4.5: Identification of Asp and Asn isoforms: (A) MALDI-TOF-MS of native meob 1 linearized 
product of meob 1 after reduction, alkylation and enzymatic digestion with endo-Glu-C of expected 3304.3 Da 
[M+H]. (B) b-series ions obtained from MS/MS fragmentation b21 (1229.0
2+
), b22 (1286.5
2+
) and b24 
(1315.0
2+
). (C) b-series ions obtained from MS/MS fragmentation y7 (733.3), y8 (848) and y9 (978.4). The 
isotopic distributions of ions b21 and y7 were as expected. The C13 isotope of successive ions including b22, 
b23, y8 and y9 skewed to 1 Da lower corresponding to Asn. 
 
Unlike linear peptides, characterising de novo sequencing of cyclotides is not straightforward. 
Cyclotides are typically subjected to treatment with reducing agents in order to unknot the 
cystine knot, carboxymethylated to cap free thiol groups and treated with proteolytic enzymes 
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to cleave at the specific residues. From the analysis, the proposed sequence for mede_VC 1 
contains a Asp in loop 6 and has a theoretical mass of 2936.3 Da which should yield a 
[M+H]
+
 of 2936.3, thus there is a 1 mass unit discrepancy. This is likely due to the "real" 
peptide containing an N in loop 6, which is deamidated to yield the Asp form during sample 
preparation.  
Deamidation is the conversion of an amide group (i.e Asn) into a charged acid (i.e Asp) 
through liberation of ammonia. It has been found that plant proteins undergo deamidation in 
the presence of heat, acidic/basic and enzymatic hydrolysis.  The amide bonds in the side 
chains of these amino acids (Gln and Asn) are susceptible to hydrolysis by releasing 
ammonia and transforming into acidic groups (Glu and Asp respectively). In reality, studies 
have shown that food processing (i.e breakfast preparation) conditions including heat, pH and 
water affect the deamidation. As discussed elsewhere in this thesis, cyclotides are a major 
class of plant derived macrocyclic peptides. Typically, most cyclotides contain highly 
conserved residues Asn/Asp at Proto-C-termini which are involved in cyclisation events and 
has been confirmed by DNA sequence data In the process of de novo sequencing, cyclotides 
were subjected to pH, heat (37° C) and enzymatic treatments. In support of the literature and 
observations in this study, I conclude that cyclotides undergoing deamidation is primarily due 
to sample preparation conditions. [4, 5]. 
4.4.3 Why do many plants produce many cyclotides? 
To date ~300 cyclotides have been discovered and most of them are species specific and 
seldom repeated in more than one plant. Why do plants produce cyclotides with such high 
sequence diversity? It has been believed that the primary role of cyclotides in plants is that of 
a defensive purpose. It seems likely that plants produce a variant number of cyclotides 
suitable to different types of pests as part of their defence role. It has been noted that the 
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cyclotide profile also varies with seasonal variation that reflects the variations in the pest 
populations [6].  
 
Plants produce a multitude of cyclotides, yet few of them are also expressed in different 
plants species, sometimes even in phylogenetically distant families. For instance, kalata B1 
was initially discovered in O. affinis (Rubiaceae), but later studies showed its presence in 
other plant species, including V. odotora, and V.philiphinica [7]. Varv A was initially 
identified in V. tricolor, V. arvensis, V. odorata and O. affinis [7, 8]. It is even more 
interesting to note that kB1 was found in O. affinis and V. odorata, however, their genes are 
different in these plants. For instance, in O. affinis kB1 derives from Oak1 gene encoding a 
single mature cyclotide domain, whereas in V. odorata, kB1 derives from second of three 
cyclotide domains from Vok1 gene. In the current study, meob 1 was found in two different 
plants species M. dentatus and M. obovatus, which belong to the same genus. On the other 
hand, glsp 1 was found in G. sphaerocarpum and L. triandra listed in (Table 4.1). 
Interestingly, cycloviolacin O12 and kalata S were found in 18 plant species (Table 4.1).  
 
4.4.4 Biosynthesis insights of cyclotides  
The discovery of precursors of kalata B1 and B2 from cDNA library of O. affinis (Rubiaceae 
family) has revealed that cyclotides are ribosomally synthesised products [11]. Since the 
original discovery, cyclotide precursors from many plant families, including Violaceae [12], 
Fabaceae [13], Solanaceae [14] and Cucurbitaceae, have been discovered. The discovery of 
cyclotide genes significantly contributed to the understanding of their biosynthesis 
mechanism. 
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It is believed that asparaginyl endopeptidase (AEP) plays an important role in biosynthesis of 
cyclotides [15]. AEPs are cysteine proteinases, also known as vacuolar processing enzymes 
which commonly occur in plants possessing specificity to C-terminus of Asn or less 
efficiently at Asp [16]. All cyclotides so far characterised possess a highly conserved 
Asp/Asn in loop 6, which strengthens the idea of cyclisation of cyclotides through AEP. 
Violacin A is an acyclotide from V. odorata without head to tail cyclic backbone which is in 
agreement with the observation that the gene encoding violacin A lacks the Asn/Asp in loop 
6 and is replaced with stop codon [17]. Lacking the element requirements for cyclisation 
events, violacin A remains a linear precursor. Furthermore, cyclotide precursor expression in 
transgenic plants also evidenced the involvement of AEP and Asn/Asp at C-terminal [15].   
 
4.4.5 Distribution of cyclotides among plant kingdom 
As already noted, cyclotides have been discovered in plant families including the Violaceae 
[18], Rubiaceae, Cucurbitaceae [19], Fabaceae [20] and the Solanaceae [14]. However, 
complete understanding on the origin and distribution of cyclotides remains tantalising, 
which primarily motivated me to pursue this investigation in large sets of plant species. 
Plants that have been found to express cyclotides have no direct phylogenetic link, suggesting 
that cyclotides could have evolved independently in distant families. One plausible 
explanation for this distribution of cyclotides among plants is through either convergent 
evolution or lateral gene transfer [21]. In order to fit the theory of lateral gene transfer, 
cyclotides should be transferring to the entire population. It is then unlikely that cyclotides 
evolved through lateral gene transfer; not all the plant species in Rubiaceae are found with 
cyclotides. The plant families found with cyclotides do not have any common ancestor; hence 
divergent evolution is also not likely. The possible conclusion from this suggests cyclotides 
evolved through convergent evolution. It has been noted that the structural similarity of 
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knotted proteins among animals and plants is due to convergent evolution [22]. The cystine 
knot motif was found in linear precursors of peptides expressed in many animals, plants, 
bacteria, fungi and viruses that play a crucial role in a defence mechanism and their template 
act as a pharmaceutical factory [22]. The occurrence of cystine-knotted peptides among 
living organisms suggests the backbone cyclisation occurred after the formation of cystine 
knot motif.   
 
4.5. Conclusions  
The current study results demonstrate that cyclotides are a large class of plant derived 
macrocyclic peptides among and notably ubiquitous in Violaceae family. The combination of 
various analytical techniques enabled to characterise novel cyclotide sequences. The analysis 
of novel cyclotides led to the following conclusions:  
1. Previous studies reported the existence of Asn and Asp forms of cyclotides. Mass 
spectrometric analysis of many cyclotides in this study show mixtures of Asp and Asn 
isoforms and suggest deamidation of Asn to Asp is due to pH, temperature and/or 
enzymatic treatment during sample preparation 
2. The discovery of kalata S and cycloviolacin O12 in 18 plant species suggests a 
common set of enzymes and processing machinery among plants.  
3. Overall this work has providednew insights into the distribution of cyclotides and 
their biosynthesic origins. In Chapter 5, I build on this work by examining 
mechanistic aspects of cyclotide bioactivity.   
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Chapter 5 
 
Mode of action of cyclotides: cryo-TEM 
imaging of cyclotide-membrane interactions 
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5.1 Abstract 
Cyclotides can be regarded as a naturally occurring combinatorial library of peptides 
originating in plants and exhibiting a wide range of pharmaceutically important biological 
activities, including anti-HIV and cytotoxicity towards cancer cell lines [1, 2]. Many 
naturally isolated cyclotides tested so far displayed cytotoxicity towards red blood cells and 
broad cancer cell lines [1, 2]. It is believed that the commonality of activity towards 
biological cells is due to the interaction against biological membranes [1-3, 5]. In supporting 
this hypothesis, recent biophysical studies showed that cyclotides target and disrupt 
biological membranes, which is a prime driving force for their biological activities [1-3, 5]. 
Additional studies demonstrated that cyclotides have lipid specificity and revealed that 
cyclotides target phospholipids containing a phosphoethanolamine (PE)-head group.  
 
To further confirm the hypothesis that cyclotides target phospholipids containing PE-
headgroups, the membrane-binding properties of eight novel cyclotides with a range of 
sequence diversity were studied. From surface plasmon resonance measurements and 
membrane leakage studies, it is clear that these novel cyclotides also target PE-containing 
phospholipids. To obtain more information on the disruption mechanism, a cryo-transmission 
electronic microscopy (cryo-TEM) imaging technique was utilized. Compared to light 
microscopes, samples can be visualized at higher resolution with cryo-TEM. To understand 
how cyclotides disrupt biological membranes, the cryo-TEM imaging technique was used on 
large unilamellar vesicles (LUVs) composed of palmitoyloleoylphosphatidylcholine (POPC) 
and palmitoyloleoylphosphatidylethanolamine (POPE) and revealed that cyclotides interact 
with membranes and form pore-like structures.  
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5.2 Materials and methodologies 
The background and methods/techniques used in this study are detailed in Chapter 2 
(Sections 2.1.1 to 2.1.9).  
 
5.3 Results and discussion 
5.3.1 Extraction and purification of selected cyclotides 
The main objective of the current study was to expand the understanding on the mechanism 
of action of cyclotides towards mammalian cells. A suite of novel cyclotides (mede_VC 1 – 4 
and mede_BM 1-4 see Table 5.1) isolated and purified from M. dentatus (from Victoria) and 
M. dentatus (from Blue Mountains) was included in this study. 
 
Table 5.1. Novel cyclotides discovered from M. dentatus species. 
S. No Peptide Peptide sequence Mass(Da) Net charge Source 
1 mede_VC 1 GIPT-CGETCTIGTCNTPG—CTCSWPICTKN  2936.2 0 M. dentatus (VIC) 
2 mede_VC 2 GSIP-CGESCVYIPCISSVIGCACKSKVCYKN 3187.4 2 „‟ 
3 mede_VC 3 GSIP-CGESCVWIPCISSVVGCACKNKVCYKN 3223.4 2 „‟ 
4 mede_VC 4 GTIP-CGESCVYIPCITVVSGCSCKNKVCYKN 3244.4 2 „‟ 
5 mede_BM 1 GIPICGETCFFGKCNTPK--CTCINPI-CYKN 3142.4 2 M. dentatus (BLM) 
6 mede_BM 2 GIP-CAESCVYIPCISGVIGCSCKNKV-CYRN 3154.4 2 „‟ 
7 mede_BM 3 GTIPCGESCVYIPCITSAIGCSCKNKV-CYRN 3257.4 2 „‟ 
8 mede_BM 4 GIPICGETCFFGKCNTPK--CTCNKPI-CYKN 3157.4 2 „‟ 
9 cyO2 GIPCGESCVWIPCISSAIGCSCKSKV—CYRN 3138.4 2 V.odorata 
10 kB1 GLPVCGETCVGGTCNTPG-CTCSWPV—CTRN 2890.1 0 O. affinis 
11 mela 2 GKPTCGETCFKGKCYTP--GCTCSYPL-CKKN  3092.3 4 M. latifolius 
M. dentatus (VIC) and M. dentatus (BLM) are named based on their location of collection in Victoria (VIC) and 
Blue Mountains (BLM), respectively.  
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The discovery and characterization of cyclotides listed in Table 5.1 was described in 
Chapter 4. These cyclotides were selected for this study based on their abundance in plant 
material, sequence diversity and contrasting elution profiles in RP-HPLC. Furthermore, the 
prototypic cyclotides CyO2, kB1 and mela 2 are representative of bracelet, Möbius and Lys-
rich Möbius subfamilies, respectively, and were also included for comparative analysis.  
5.3.2 Membrane binding properties  
The mode of action of selected cyclotides (Table 5.1) belonging to the bracelet and Möbius 
subfamilies was evaluated on a range of model membranes systems using a combination of 
SPR measurements, fluorescence studies and cryo-TEM imaging. The results from the SPR 
and fluorescence studies unequivocally support previous studies that cyclotides target and 
disrupt lipid membranes [1-3].  
Phosphocholine (PC)-containing phospholipids are the most abundant phospholipids in 
eukaryotic cell membranes. Hence, in the current study, model membranes were prepared 
with POPC as a major component, due to the fact that it forms zwitterionic phospholipid 
bilayers in fluid phase at room temperature (25
o
C) [4]. All the selected cyclotides showed 
very weak or no binding to POPC lipid bilayers (Figure 5.1 A). To observe, the influence of 
negative charge on affinity of cyclotides, POPG, a phospholipid containing an anionic 
headgroup was added. It is interesting to note that all cyclotides showed no binding or very 
weak binding even in the presence of negatively-charged membranes (Figure 5.1 B). The 
binding potential of all cyclotides was quantified based on peptide-to-lipid molar ratios (P/L) 
and Kd (dissociation constant, concentration required to achieve half-maximal binding at 
equilibrium) presented in Table 5.2 and Figure 5.1. 
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Figure 5.1: Membrane-binding potential of cyclotides. The membrane-binding affinity of the novel 
cyclotides (Table 5.1) was evaluated using SPR measurements against model membranes composed of (A) 
POPC, (B) POPC/POPG (80:20), (C) POPC/POPE (80:20) or (D) POPC/POPE/POPG (60:20:20). Peptide-to-
lipid ratios (P/L) were calculated on the basis of the total amount of lipid deposited on the chip and to the total 
amount peptide bound to the lipid bilayer (1 RU = 1 pg.mm
-2
) at the end of the peptide injection (t = 160 s). The 
obtained data from sensorgrams was fitted with a nonlinear regression using a sigmoidal binding with Hill slope 
in Graphpad Prism Version 5.0. 
 
Studies have reported that PE-head group containing phospholipids influence the membrane 
binding potential of cyclotides [2, 3, 5]. The addition of POPE to POPC (i.e. POPC/POPE 
(80:20)) resulted in an increase of membrane binding affinity. Furthermore, addition of the 
negatively charged POPG to POPE-containing membranes (i.e. POPC/POPE/POPG 
(60:20:20)) further increased the affinity of all the peptides in this study (Figure 5.1 C). This 
effect is more evident in peptides that possess a higher positive net charge. Mela 2 is the most 
positively charged peptide in the series, has an enhanced affinity for POPC/POPE/POPG 
compared to POPC/POPE. For instance, the affinity of mela 2 to POPC/POPE was found to 
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be at Kd of 58.88 µM, whereas addition of POPG resulted in an enhanced affinity for 
POPC/POPE/POPG with a Kd of 12.28 µM (Table 5.2). This suggests the involvement of 
electrostatic attractions between negatively charged PG-head groups and the molecular 
surface of cyclotides with more positively charged residues. 
 
Figure 5.2: Comparison of binding of mede_VC 2 and mede_VC 3 in the presence of PE-phospholipids. 
Sensorgrams obtained with (A) mede_VC 2 and (B) mede_VC 3 injected over phospholipid bilayers composed 
of different lipid mixtures followed by SPR analysis. For a comparison, the amount of peptides bound to lipid 
bilayers was evaluated at 16 μM at the end of association phase (160 s of peptide injection). The dissociation 
phase for both the peptides was followed for 600 s. 
  
Regardless of sequence diversity, all cyclotides from both subfamilies exhibited identical 
specificity towards PE-containing phospholipids compared to other lipids (Table 5.2). It 
should be noted that compared to bracelet members, Möbius members showed lower affinity 
for the tested model membranes. For example, mede_VC 1, a Möbius subfamily member 
showed the lowest affinity for all model membranes (Table 5.2). Overall, the data suggest 
that PE-head group containing phospholipids are crucial for the ability of cyclotides to bind 
to lipid membranes. 
 
In the SPR experiments, the sensorgrams obtained to evaluate the membrane binding 
affinities were fitted well with sigmoidal binding to the Hill slope equation. In the case of 
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mede_VC 3, it seems to bind strongly to POPC/POPE (80:20), and the shape of the curve 
suggests that the peptide removes lipid from the chip surface (Figure 5.2 B).  
 
5.3.3 Do cyclotides permeabilize lipid membranes? 
One of the objectives in this study was to understand membrane permeabilization properties 
of cyclotides. The permeabilization ability of selected cyclotides (Table 5.1) was determined 
using a membrane leakage assay. In agreement with previous studies, there has been 
significant correlation observed between the ability of cyclotides to bind model membranes, 
as examined by SPR and ability to disrupt vesicles, as monitored by fluorescence 
measurements.  
 
Table 5.2. Membrane binding and vesicle permeabilization properties of cyclotides. 
POPC/POPE (80:20) POPC/POPE/POPG (80:20:20) 
 
P/L max
a
  
(mol/mol) Kd (μM)b  LC50
c (μM) P/L max (mol/mol) Kd (μM)b  
LC50 
 (μM) 
mede_VC 1 0.15 ± 0.01 24.5 ± 1.44 4.87 ± 0.93 0.20 ± 0.01 22.55 ± 1.06 7.46 ± 0.59 
mede_VC 2 0.3 ± 0.01 6.82 ± 0.35 0.56 ± 0.05 0.31 ± 0.00 4.32 ± 0.09 1.02 ± 0.23 
mede_VC 3 0.13 ± 0.01 7.47 ± 0.86 0.30 ± 0.04 0.29 ± 0.00 4.99 ± 0.19 0.41 ± 0.12 
mede_VC 4 0.29 ± 0.01 10.56 ± 0.42 0.49 ± 0.11 0.28 ± 0.01 5.03 ± 0.22 1.32 ± 0.14 
mede_BM 1 0.30 ± 0.01 17.9 ± 0.65 0.70 ± 0.09 0.37 ± 0.01 12.36 ± 0.39 1.06 ± 0.12 
mede_BM 2 0.32 ± 0.01 6.33 ± 0.25 0.16 ± 0.01 0.34 ± 0.01 N/A 0.31 ± 0.02 
mede_BM 3 0.31 ± 0.00 3.79 ± 0.12 0.36 ± 0.04 0.33 ± 0.01 2.73 ± 0.14 0.26 ± 0.02 
mede_BM 4 0.19 ± 0.01 17.77 ± 1.52 1.70 ± 0.24 0.36 ± 0.01 8.98 ± 0.36 0.80 ± 0.01 
mela 2  0.20 ± 0.02 58.88 ± 13.51 >10 0.30± 0.02 12.28 ± 1.39 2.15 ± 0.42 
CyO2 0.29 ± 0.00 2.89 ± 0.15 0.31 ± 0.05 0.33 ± 0.01 1.94 ± 0.10 0.18 ± 0.02 
 
N/A: the Kd was not determined as the curve could not be fitted with sigmoidal binding to the Hill slope 
equation.   
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As shown in Table 5.2, all cyclotides induced leakage in the presence of POPE and the 
leakage efficiencies were compared using the LC50 (the concentration of peptide required to 
induce leakage in 50% of the vesicles). Amongst all the cyclotides, the highest 
permeabilization abilities were observed with CyO2 and mede_BM 2 whereas mede_VC 1 
had the lowest leakage propensity. 
 
The permeabilization ability was also examined for membranes containing both POPE and 
the negatively-charged POPG. Interestingly, most cyclotides showed a identical ability to 
permeabilize POPC/POPE/POPG and POPC/POPE, Mela 2 has an enhanced 
permeabilization ability in the presence of POPG which can be explained by increased 
electrostatic forces between the net positive charge of mela 2 and the negatively-charged 
POPG. However, although all cyclotides showed selectivity and an ability to permeabilize 
PE-containing membranes, their exact mode of disruption is unknown.  
 
5.3.4 Correlation between membrane binding potential and biological activities 
Cyclotides are generally regarded as cytotoxic as they display toxicity against cancer cell 
lines, RBC, HIV particles and insects [1]. It is believed that the natural function of cyclotides 
in plants is defence purposes against pests [7], nematodes [8] and molluscs [9]. Many plant 
defensin peptides described so far are antibacterial [10]. Most antibacterial peptides share 
common biophysical properties, including positively charged residues and high cysteine 
content [10].  
 
Interestingly, even when they are positively-charged, most cyclotides characterized to date 
exhibit very low or no antibacterial activity. Indeed, cyclotides tested in this study, including 
mede_VC_1 to mede VC_4 and mela 2 did not show antibacterial activity. The lack of 
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antibacterial potential can be explained by the membrane binding specificity and bacterial 
membrane composition [1].  
 
The cytotoxicity of selected cyclotides towards cancer cell lines including melanoma 
(MM96L), cervical cancer (HeLa) and human foreskin fibroblast (HFF-1) was evaluated 
(Table 5.3). The cytotoxic effects of mede_BM 1 to mede_BM 4 against MM96L and HFF-1 
were not evaluated due to insufficient amount of peptides. As can be seen from the results, all 
the selected cyclotides exhibited cytotoxicty at low micromolar range. Among all the 
cyclotides, CyO2 was the most toxic whereas mede_VC 1 and mede_BM 1 were the least 
effective against all cell lines tested.  
 
Table 5.3. Cytotoxic (CC50
*
) and hemolytic (HC50
*
) properties of cyclotides included in this study.  
Peptide MM96L HFF-1 HeLa RBCs 
mede_VC 1 21.94 ± 1.9 12.45 ± 0.99 36.92 ± 3.25 >64 
mede_VC 2 2.11 ± 0.30 1.42 ± 0.08 3.64 ± 0.35 10.57 ± 1.374 
mede_VC 3 2.69 ± 0.28 1.69 ± 0.11 3.18 ± 0.20 4.81 ± 0.34 
mede_VC 4 3.97 ± 0.14 2.88 ± 0.18 9.87 ± 0.343 10.48 ± 1.09 
mede_BM 1 - - 26.66 ± 2.58 48.02 ± 3.11 
mede_BM 2 - - 2.28 ± 0.12 19.39 ± 1.92 
mede_BM 3 - - 2.06 ± 0.18 35.38 ± 2.9 
mede_BM 4 - - 3.82 ± 0.24 57.51 ± 6.04 
CyO2 1.15 ± 0.04 0.9 ± 0.05 2.19 ± 0.12 10.1 ± 0.94 
CC50
*
 and HC50
* 
are the concentrations of cyclotides required to kill 50 % of cancer cells and red blood cells, 
respectively. 
 
Several studies have suggested that cyclotides have hemolytic properties [1]. In support of 
this observation, all selected cyclotides in this study showed hemolytic activity (Figure 5.3).  
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The highest hemolytic activity was displayed by mede_VC 3, with a HC50 of 4.81 µM while 
mede_VC 1 has the lowest hemolysis, with HC50 of >64 µM (Table 5.3). Mede_VC 1 is the 
least cytotoxic towards both cancer cell lines and hemolytic cells (Table 5.3). It is 
noteworthy that the trend in hemolytic activity correlates with the trend observed in 
membrane permeabilization ability in POPC/POPE vesicles. 
 
Figure 5.3: Toxicity of selected cyclotides against red blood cells was evaluated by hemolytic assay. All the 
peptide samples were tested in triplicate and HC50 determined to quantify the hemolytic abilities (see Table 
5.3).  
 
Results from this and previous studies [1] show that cyclotides target mammalian cells. The 
ability to target mammalian cells can be explained through membrane composition and 
specificity to phospholipids. For instance, mammalian cells have 40 to 50% of PC-containing 
phospholipids and 20 to 50% of PE-containing phospholipids [11].  
 
Besides the fact that all major classes of phospholipids are present in all the cell organelle 
membranes, their distribution varies in different organelles. Furthermore, these phospholipids 
are asymmetrically distributed across the bilayers of membranes.  In biological membranes, 
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PE-phospholipids are asymmetrically distributed across the bilayer, i.e., 80% of the total PE 
composition is confined to the inner cytosolic leaflet [12], whereas PC and sphingomyelin 
(SM) are more abundant in the outer leaflet [6]. The outer layers of RBC possess 
approximately 5% of PE-phospholipids [13]. However, the cyclotides tested to date have 
been shown to be haemolytic, suggesting this amount is sufficient to facilitate binding.  
 
The ability of cyclotides to bind to model membranes composed of low levels of PE can be 
explained through transbilayer movement of phospholipids. Transbilayer movement or flip-
flop is a phenomenon of passing the polar headgroup of a lipid through a hydrophobic layer 
to the opposing bilayer. It should be noted that phospholipids are symmetrically distributed in 
model membranes, while in biological membranes they are asymmetrically distributed. The 
transbilayer movement of phospholipids in biological membranes is an energy driven process 
catalyzed by enzymes [14, 15]. Moreover, studies have demonstrated the acceleration of 
transbilayer movement upon addition of proteins or peptides to the lipids. Studies with kB1 
showed its ability to induce transbilayer movement of phospholipids [2], and considering the 
structural and functional similarities with the other cyclotides it is plausible to hypothesize 
that this phenomenon can also be induced by other cyclotides. 
 
5.3.5  Cryo-TEM analysis of cyclotide-membrane interactions 
In recent years, cryo-TEM has emerged as a technique to characterize morphology of 
nanostructures [16]. Unlike other microscopic techniques, cryo-TEM does not require any 
staining or chemical fixation of samples. The samples can be directly transferred to TEM 
grid, but need to be vitrified before imaging. Vitrification is a process of transformation of 
solutions into glass-like state [17], which brings the samples to be visualized at atomic 
resolution in near native state. The process of vitrification can be achieved by rapid freezing 
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of liquids [18]. This technique enabled the imaging of the disruption of liposomes composed 
of POPC/POPE (80:20) induced by prototypic cyclotides, including CyO2, kB1, mede_BM 4 
and mela 2. These cyclotides were selected on the basis of their biophysical properties as 
described below: 
 
CyO2 CyO2 is the prototypic bracelet cyclotide and displays strong cytotoxic 
activities against cancer cell  lines [19], bacteria cells [20] and red blood cells 
[1].  
kalata B1 kB1 is the prototypic Möbius cyclotide and its membrane binding properties 
and biological activities have been extensively examined [1-3, 5]. 
mede_BM 4 mede_BM 4 is a novel cyclotide identified in this thesis (Chapter 4) and was 
included due to its high hydrophobicity and ability to bind and permeabilize 
model membranes.  
mela 2 mela 2 is a Lys-rich cyclotide with net positive charge of +5 and it was 
included to examine the influence of positive charges on membrane disruption 
properties of cyclotides (first described in Chapter 3).  
 
Samples with a peptide-to-lipid ratio of 1:10 were incubated at various time points between 
30 s and 600 s. LUVs composed of POPC/POPE (80:20) were used as controls to analyse the 
shape of vesicles (Figure 5.4 A–D). As the peptides studied have different membrane-
binding kinetics, affinity and permeabilization efficiency (see Table 5.2 and Figure 5.1), 
incubation times varied for the different peptides. For instance, CyO2 was incubated with 
vesicles for 30s (longer incubation times induced total disruption of the vesicles) before 
vitrification, whereas mela 2 was incubated with vesicles for 600s before sample vitrification 
and imaging.  
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5.3.5.1  Vesicles shape without peptide 
As can be seen in the control images, most of the liposomes are predominantly unilamellar, 
have a spherical shape and an average size of 100 nm in diameter. In addition to regular 
liposome structures, open liposomes, disc-like structures, long elongated needles, irregular 
flakes and multi lamellar vesicles are also present in the control sample (Figure 5.4 A-D). 
 
 
Figure 5.4. cryo-TEM investigation of cyclotide-membrane interactions: images from A-D are LUVs in the 
absence of peptides. Changes in morphology of LUVs in the presence of (E) kB1, (F) mela 2, (G) mede_BM 4 
and (H-K) CyO2 are shown. 
5.3.5.2  Morphological changes induced by kalata B1 
The time dependant morphological changes in phospholipid vesicles treated with kalata B1 
are shown in Figure 5.5. The liposomes were incubated at various time points, including 30 s 
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and 180 s. As can be seen in the Figure 5.5, compared to control liposomes kalata B1 treated 
liposomes have undergone multiple morphological changes at both at 30 s (Figure 5.5 A-C) 
and 180 s (Figure 5.5 D-F). For instance, the unilamellar vesicles were changed to 
multilamellar vesicles after 30 s of incubation and the distance between the vesicles was 
significantly reduced. Furthermore, at 180 s the size of multi-lamellar vesicles was further 
increased (approximately 500 to 600 nm), probably due to aggregation of the large 
unilamellar vesicles (Figure 5.5 D-F), as suggested by Figure 5.5 E in which the multi 
layered lamellar vesicles seem to form by merging multiple individual LUVs. The 
morphological changes in the vesicles suggest that kalata B1 has a tendency to aggregate the 
phospholipid vesicles, which is in agreement with previously published studies [1, 2].  
 
 
Figure 5.5. cryo-TEM investigation of kalata B1-liposome interactions: The images of interactions of kalata 
B1 with liposomes were taken after (A-C) 30 s and (D-F) 3 mins of incubation. 
5.3.5.3 Morphological changes induced by mela 2 and mede_BM 4 
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Unlike kB1, the addition of mela 2 (Figure 5.4 F) and mede_BM 4 (Figure 5.4 G) converted 
the liposomes into bilayer portions after incubation for 300 sec. In addition, long thread like 
micelles can also be noticed and are not well structured like bilayer discs. As can be seen in 
Figure 5.4 F-G, compared to control liposomes (Figure 5.4 A-D), local 
disturbance/permeabilization seems to occur within the vesicle suggesting localized pore-like 
structure that results in breaking the vesicle into smaller bilayer portions. For instance, as can 
be seen in Figure 5.4, control liposomes are spherical, while in the presence of peptides the 
outer bilayer portions have kinks suggesting local disturbances. This eventually resulted into 
permeabilization of bilayers (holes punched in the membrane) followed by lost of the 
liposome shape and breaking into portions of bilayers (Figure 5.4 F) (Figure 5.4 G).  
 
5.3.5.4  Morphological changes induced by cyO2 
Figures selected from the samples containing cyO2 show a systematic disruption of 
phospholipid bilayers (Figure 5.4 H-K); for instance, panel H shows the disturbance of the 
bilayer structure in a small portion of the vesicle, whereas panels I and J show disturbance in 
a larger portion of the vesicle. In Panel K the vesicle and bilayer structures are lost, 
suggesting a “solubilization” of the bilayer induced by cyO2. 
 
5.3.6 Membrane disruption mechanism 
Membrane surfaces attain stability through combination of electrostatic forces and van der 
Waals interactions, whereas two approaching membrane surfaces are repelled through 
repulsive forces [21]. Membrane active peptides or proteins have a tendency to destabilize 
these forces and reduce the proximity between two membrane surfaces and induce vesicle 
aggregation [21]. The current and previous studies [1, 2] provide evidence that cyclotides 
possess a conserved ability to specifically target PE-phospholipids and to disrupt lipid 
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membranes. However, their membrane disruption properties are peptide dependent. For 
instance, Henriques
 
and co-authors demonstrated ability of cyclotides to aggregate vesicles: 
the highest aggregation was noticed in the presence of cyO2 and followed by kB1 [1], 
whereas no aggregation was observed in the presence of kB8.  
 
The ability of cyclotides to target and disrupt membranes seems to correlate with 
hydrophobic properties. For instance, cyO2 and kB1 are significantly cytotoxic against 
cancer cell lines and red blood cells. On the other hand, kB8 is relatively less hydrophobic as 
evidenced from its early retention time in HPLC [23] and its lack of hemolytic activity. 
Furthermore, the hydrophobic properties also correlated with the ability of cyclotides to 
aggregate vesicles: cyO2 and kB1 showed high aggregation of vesicles, whereas the presence 
of kB8 induced low vesicle aggregation. 
 
Most cyclotides have conserved molecular surface regions, including a hydrophobic patch 
and a bioactive patch that are involved in targeting and insertion into the membranes [1]. For 
instance, it was known that a bioactive patch is essential for targeting PE-head groups while a 
hydrophobic patch is important for insertion into the hydrophobic core of membranes [1]. 
Therefore the molecular surface properties correlate well with the high cytotoxic properties of 
kB1 and cyO2. Also the molecular surface representation of kB8 shows the presence of a 
lower number of surface exposed hydrophobic residues, which correlated with lower 
hemolytic activities. These hydrophobic and bioactive patches are highly conserved in mela 
2, a positively charged cyclotide.  
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5.4 Conclusions 
The current study explored the mode of action of cyclotides through a combination of 
membrane binding, permeabilization studies and cryo-TEM imaging. The conclusions that 
can be drawn from these studies are summarized below: 
1. Regardless of sequence diversity, phospholipids containing PE-headgroups are crucial 
for the ability of cyclotides to bind model membranes.  
2. Morphological analysis undertaken by cryo-TEM revealed that cyclotides interact 
with membranes but exhibit different modes of disruption. For instance; kB1 induce 
aggregation of vesicles by increasing the proximity between two different vesicles. By 
contrast, mela 2 (Figure 5.4 F), mede_VC 4 (Figure 5.4 G) and cyO2 (Figure 5.4 H-
K) (disrupt lipid bilayers through inducing local permeabilization of membrane 
surfaces.  
 
Overall, the studies described in this chapter have provided new insights into the molecular 
basis of cyclotide action. Although much remains to be done in this field to understand the 
full extent of cyclotide membrane interactions, the work described here provides a good 
foundation. Possible future extensions of the work are identified in Chapter 6. 
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and 
future directions 
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As is apparent from the preceding chapters in this thesis, many classes of mini-circular 
proteins have been discovered in a range of organisms, including bacteria, fungi, mammals 
and plants [1]. The aim of this thesis was to understand the distribution, and sequence 
diversity of cyclotides among plant species and their mechanism of action. Amongst all of the 
classes of cyclic peptides identified to date, cyclotides are the only peptides that have a CCK 
motif formed by six cysteine residues and a cyclic backbone [2]. The thesis is organised into 
six chapters addressing two major aspects: the discovery and characterisation of cyclotides 
and the mechanism of action of cyclotides. This chapter draws together the findings of the 
thesis and makes some suggestions for future research in the cyclotide field.  
 
6.1          Discovery and characterisation of cyclotides 
Cyclotides comprise a family of plant-derived macrocyclic disulfide rich peptides and the 
number of members belonging to this family is predicted to grow as more researchers work in 
this field [3]. To date, more than 300 cyclotides have been discovered at the peptide and 
DNA levels [4-6]. Despite their large sequence diversity and high expression in plants, our 
understanding of their origin and distribution still has many gaps. One of my major aims in 
this thesis was to provide an extended knowledge on distribution and sequence diversity of 
cyclotides among plant species. The outcomes of these studies are described in Chapters 3 
and 4.   
 
The exploration of cyclotides in this thesis started with the question of why all plant species 
belonging to the Violaceae family express cyclotides. To gain more insights into the natural 
distribution and biological importance of cyclotides, I searched for cyclotides in the 
Violaceae family species M. latifolius and M. chathamicus which are geographically isolated. 
A new set of cyclotides was identified in these species that are very distinct from previously 
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identified cyclotides. In particular, they possess highly conserved lysine residues and a +5 net 
charge. By contrast, typical Möbius cyclotides carry a net charge of zero. To further 
characterise this new subfamily of cyclotides their affinity for biological membranes was 
examined using SPR and model membranes.  
 
Similar to what was observed with other cyclotides, a specificity for PE-containing 
phospholipids was found [7, 8]. This finding clearly suggests that specificity towards PE-
phospholipids is a highly conserved feature of cyclotides. Interestingly, an enhanced affinity 
was noticed in the presence of negatively charged headgroup (PG) containing phospholipids. 
This increased affinity suggests the influence of electrostatic interactions between the net-
positive charge of cyclotides and negative head group of phospholipids. Furthermore, the 
ability of cyclotides to bind model membranes correlates with their biological activities. For 
instance, compared to kalata B1 and cyclociolacin O2, Lys-rich cyclotides discovered in this 
thesis displayed lower cytotoxicity towards haemolytic cells (refer to Chapter 3). The lower 
haemolytic activities of the Lys-rich cyclotides suggests a higher safety window for potential 
drug design applications.  
 
Inspired by the discovery of novel Lys-rich cyclotides and their unusual sequence diversity, I 
undertook a high-throughput screening to extend knowledge on cyclotide distribution and 
sequence diversity. To achieve this goal, a total of 206 plant species belonging to 46 families 
was selected on the basis of their traditional medicinal values and phylogenetic proximity to 
plants containing cyclotides. As a result, 31 plant species were identified that contained 
cyclotides. Fifty novel cyclotides were isolated and purified using a combination of LC-MS 
and HPLC techniques and their de novo sequences were characterised using tandem mass 
spectrometry. Among all the plants screened, all Violaceae family members showed the 
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presence of cyclotides, confirming that the Violaceae is a rich source of cyclotides. One 
interesting discovery was the deamidation of Asn in cyclotides under external factors, 
including pH, temperature and enzymatic digestion. Although this phenomenon is often 
observed among peptides, it was unknown in cyclotides until now. Previous studies reported 
the occurrence of cyclotide sequences in plant species that are phylogenetically distant. 
Interestingly, kalata S and cycloviolacin O12 were found in 19 plant species that belong to 
the Rubiaceae and Violaceae families.  
 
From the series of studies in this thesis, it can be seen that cyclotides are a most diverse and 
fascinating class of naturally occurring molecules. Among all the plants screened in this 
thesis, all species belonging to Violaceae family were found to express cyclotides. On the 
other hand, only two (Hedyotis centranthoides and Palicourea guianensis) out of 10 plant 
species belonging to the Rubiaceae family were found with cyclotides. The Rubiaceae is the 
fourth largest family and contains many economically important plants, such as coffee; so it 
will be of interest to see if cyclotides are found in other members of this family in future [9]. 
In recent studies, cyclotides with unusual biosynthetic mechanisms were discovered in 
Clitoria ternatea (commonly known as butterfly pea), a plant belonging to the Fabaceae plant 
family. The Fabaceae family, with approximately 20,000 species classified under 650 genera 
[10], is a significantly natural resource with many agriculturally, medicinally and industrially 
important plants [10]. Overall in this screening program, only two out of ten Rubiaceae 
species contained cyclotides and that none out of 85 Fabaceae contained cyclotides. In this 
thesis, the large-scale discovery program suggests that Violaceae plant family is a rich source 
of cyclotides. The existence of cyclotides in every Violacea species so far screened suggests 
that cyclotides are ubiquitous in this plant family. 
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6.2           Mechanism of action of cyclotides 
Cyclotides display a broad spectrum of biological activities, including uterotonic, anti-HIV, 
anti-microbial, insecticidal and cytotoxic to cancer cell lines [11]. One of the intriguing 
questions is how cyclotides display such a range of biological activities and what is their 
mechanism of action towards biological cells? Aiming to address this question, a set of ten 
novel cyclotides from M. dentatus (Victoria) and M. dentatus (Blue Mountains) along with 
prototypic cyclotides including CyO2, kB1 and mela 2 were studied for their membrane 
targeting and permeabilisation properties. The membrane binding affinity of cyclotides was 
evaluated on model membranes composed of individual and a mixture of phospholipids at 
different molar ratios using SPR as described in Chapter 5. The permeabilisation properties of 
selected cyclotides were evaluated on the basis of CF-fluorescence dequenching experiments. 
It is noteworthy that all tested cyclotides, regardless of their sequence diversity, showed 
affinity for model membranes containing PE-phospholipids. This result is further supportive 
of the hypothesis that PE-headgroup containing phospholipids are important for cyclotides to 
target and disrupt biological membranes [8, 12, 13].  
 
The CF-fluorescence dequenching experiments in this thesis and previous reports clearly 
indicate that cyclotides disrupt biological membranes. However, the mode of disruption 
remains inconclusive. In order to dig into more details of this aspect, CyO2, kB1, mede_BM 
4 and mela 2 were selected as prototypic cyclotides to understand the membrane disruption 
mechanism using cryo-TEM imaging techniques. The results clearly indicate that the 
membrane disruption mechanism is cyclotide sequence dependent.  
 
The results of the current study, along with previous reports, allowed us to conclude that 
cyclotides are a unique family of plant derived membrane active peptides, as they exert 
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biological activities through targeting and disruption of biological membranes. Their 
amenability to chemical synthesis and tolerance to residue substitutions in the CCK 
framework engender them as an attractive framework in pharmaceutical drug design. 
Furthermore, their natural array of biological activities and resistance to proteolytic enzymes 
are added advantages. Toxicity is one of the major setbacks in pharmaceutical drug design. 
The Lys-rich cyclotides might be a better framework for drug design applications then earlier 
studied cyclotides, as they have lower haemolytic activities, and some are significantly less 
toxic to cancer cell lines.  
 
6.3          Future directions 
The findings of this thesis resulted in a number of interesting prospects for future studies. 
These include: 
1. Screening of plant species that are phylogenetically related to plants reported to 
possess cyclotides will provide an extensive understanding of sequence diversity, and 
distribution of cyclotides among plants.  
2. Most of the cyclotides tested so far are haemolytic, which narrows down the 
therapeutic window for cyclotide based drug design. Lys-rich cyclotides have been 
shown to have relatively lower haemolytic than other cyclotides. Furthermore, the 
Lys-rich cyclotides have shown cytotoxicity towards several cancer cell lines as well 
as having lower haemolytic activities than traditional cyclotides. The information 
gathered here can be used for the rational design of novel cyclotides with therapeutic 
properties. 
3. The presence of posttranslational modifications in cyclotides seem rare or non-
existent but if would be of further interest to more fully explore this aspect of 
sequence diversity. 
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4. There is great scope for more biophysical studies on cyclotides, as expanded below. 
 
In this thesis, SPR and fluorescent measurements clearly demonstrated that PE-containing 
phospholipids are pivotal for the ability of cyclotides to bind to and disrupt membranes. 
Cryo-TEM imaging reveals that the membrane disruption mechanism is sequence dependent. 
Further insights into the molecular basis of membrane architecture and cyclotide behavior in 
phospholipids is required to understand the nuts and bolts of the mechanism of action. 
Analytical techniques such as SPR, calorimetry, fluorescence spectroscopy, circular 
dichroism, NMR, AFM, isothermal titration calorimetry and chromatographic retention, 
could be used to study peptide membrane interactions [10]. However, the requirement of high 
peptide and lipid concentrations is one disadvantage of using these techniques. In future 
obtaining single-molecule level details could be advantageous as single-molecule 
visualisation techniques became more accessible.  
 
In conventional microscopy technology, the specimens are labeled with a fluorophore and 
illuminated with light. Poor resolution is one of the major hindrances in getting more insights 
into samples. In recent years, total internal reflection fluorescence microscopy (TIRFM) has 
been adapted with quantitative characterisation of peptide-membrane interaction and can be 
used to investigate the dynamics of a single molecule inside cells [14]. Detection of a single 
molecule is achievable through implementing high-end optical collection, cameras and 
relatively lower peptide (any analyte) concentration. TIRF is based on the principle that, 
when light hits an interface of two different media with varied refractive indices, partial 
diffraction and reflection occurs. At the critical angle of incidence, the light gets completely 
reflected, a phenomenon called total internal reflection. This phenomenon can be observed 
when light passes through media from higher refractive index to lower refractive index [15]. 
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This technique might thus be used to track cyclotide molecular motion during peptide 
membrane interaction studies to further explore the mechanism of action of cyclotides.  
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Table 1. Plants identified with cyclotides from studied plants. 
S. No Plant name Family name Cyclotide 
presence 
1 Andrographis paniculata Acanthaceae  
2 Hydrocarpus anthelminticus Achariaceae  
3 Actinidia arguta Actinidiaceae  
4 Alisma orientalis Alismataceae  
5 Saposhnikovia disvaricata Apiaceae  
6 Lingustium Spp. Apiaceae  
7 Typhonium giganteum tuber Araceae  
8 Acanthopanax sentica Araliaceae  
9 Phragmites communis  Arundinaceae  
10 Cynachum paniculatum Asclepiadaceae  
11 Ophiopogon japonicus Asparagaceae  
12 Asparagus cochinchinesis Asparagoideae  
13 Echinacea purpurea Asteraceae  
14 Astractylodes chinensis Asteraceae  
15 Calendula officinalis Asteraceae   
16 Astra tataricus Asteraceae  
17 Astemisia vulgaris Asteraceae  
18 Mahonia fortunei Berberidaceae  
19 Caulophyllum thalictroides Berberidaceae  
20 Platycodon grandiflorum Campanulaceae  
21 Platycodongrandiflorus Campanulaceae  
22 Codonopsis pilosula Campanulaceae  
23 Lobelia chinensis Campanulaceae  
24 Saponaria officinalis Caryophyllaceae  
25 Psedostellaria heterophylla Caryophyllaceae  
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26 Sarcandra glabra Chloranthaceae  
27 Drichosanthes kirilowii root Cucurbitaceae  
28 Trichosanthus kirilowii Cucurbitaceae  
29 Platycaldus orientalis Cupreaceae  
30 Cyperus rotundus Cyperaceae  
31 Eucommia ulmoides Eucommiaceae  
32 Pueraria lobata Fabaceae  
33 Vigna mungo Fabaceae  
34 Glycyrrhiza uralensis Fabaceae  
35 Phaseolus vulgaris Fabaceae  
36 Trigonella foenum-graecum Fabaceae  
37 Sophora japonica Fabaceae  
38 Lathyrus latifolius Fabaceae  
39 Lathyrus odoratus Fabaceae  
40 Cicer arietinum Fabaceae  
41 Chorizema ilicifolium Fabaceae  
42 Bossiaea pulchella Fabaceae  
43 Bossiaea rhombifolia Fabaceae  
44 Aotus gracillima Fabaceae  
45 Chorizema retrorsum Fabaceae  
46 Daviesia divaricata Fabaceae  
47 Daviesia flexuosa Fabaceae  
48 Daviesia corymbosa Fabaceae  
49 Daviesia genistifolia Fabaceae  
50 Bossiaea spinescences Fabaceae  
51 Bossiaea heterophylla Fabaceae  
52 Bossiaea scolopendria Fabaceae  
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53 Bossiaea brownii Fabaceae  
54 Bossiae linophylla Fabaceae  
55 Daviesia incrassata Fabaceae  
56 Daviesia horrida Fabaceae  
57 Bossiaea riparia Fabaceae  
58 Bossiaea ornata Fabaceae  
59 Brachysema sericeum Fabaceae  
60 Bossiaea webbi Fabaceae  
61 Bossiaea rhombifolia  Fabaceae  
62 Aotus procumbens Fabaceae  
63 Cajanus cinereus Fabaceae  
64 Bossiaea praetermissa Fabaceae  
65 Crotalaria benthamiana Fabaceae  
66 Daviesia pectinata Fabaceae  
67 Bossiaea preissii Fabaceae  
68 Daviesia physodes Fabaceae  
69 Daviesia angulata Fabaceae  
70 Daviesia acicularis Fabaceae  
71 Daviesia hakeoides Fabaceae  
72 Daviesia cordata Fabaceae  
73 Daviesia brevifolia Fabaceae  
74 Daviesia benthamii Fabaceae  
75 Daviesia preissii Fabaceae  
76 Daviesia benthamii  Fabaceae  
77 Daviesia leptophylla  Fabaceae  
78 Daviesia latifolia Fabaceae  
79 Daciesia longifolia Fabaceae  
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80 Daviesia mimosioides Fabaceae  
81 Daviesia nmatophylla Fabaceae  
82 Daviesia costata Fabaceae  
83 Daviesia decurrens  Fabaceae  
84 Daviesia nufiflora Fabaceae  
85 Aotus lanigera Fabaceae  
86 Aotus ericoides Fabaceae  
87 Bossiaea laidlawiana Fabaceae  
88 Bossiaea ensata Fabaceae  
89 Bossiaea foliosa  Fabaceae  
90 Bossiaea dentata Fabaceae  
91 Bossiaea cinerea Fabaceae  
92 Bossiaea eriocarpa Fabaceae  
93 Chorizema diversifolium Fabaceae  
94 Chorizema aciculare Fabaceae  
95 Chorizema cordatum Fabaceae  
96 Chorizema dicksonii Fabaceae  
97 Chorizema rhombeum Fabaceae  
98 Chorizema cordatum Fabaceae  
99 Cullen leucanthum Fabaceae  
100 Callistachys lanceolata Fabaceae  
101 Cullen australasicum Fabaceae  
102 Crotalaria mitchellii Fabaceae  
103 Crotalaria cunninghamii Fabaceae  
104 Crotalaria medicaginea Fabaceae  
105 Crotalaria eremaea Fabaceae  
106 Bossiaea aquifolium Fabaceae  
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107 Canavalia papuana Fabaceae  
108 Canavalia maritima  Fabaceae  
109 Gastrolobium celsianum Fabaceae  
110 Brachysema latifolium Fabaceae  
111 Aotus diffusa Fabaceae  
112 Swainsona formosa Fabaceae  
113 Abrus precatorius Fabaceae  
114 lathyrus odoratus (sweat pea white pearl)  Fabaceae  
115 lathyrus odoratus (sweat pea Royal family crimson) Fabaceae  
116 lathyrus odoratus (sweat pea painted lady) Fabaceae  
117 corydalis yahusuo Fumariaceae  
118 Gentiana manshurica Gentianaceae  
119 Dichroa febrifuga Hydrangeaceae  
120 Rabdosime runescentis Labiataceae  
121 Hyssopus officinalis Lamiaceae  
122 Salvia hispanica  Lamiaceae  
123 Pogostemon cablin Lamiaceae  
124 Prunella vulgaris Lamiaceae  
125 Leonorus heterophyllus Lamiaceae  
126 Scutellaria baicalensis Lamiaceae  
127 Scutellaria barbata Lamiaceae  
128 Salvia miltiorrhiza Lamiaceae  
129 Vitex trifelia Lamiaceae  
130 Taxillus chinensis Loranthaceae  
131 Ardisia japonica Myrsinaceae  
132 Fructus ligustri Oleaceae  
133 Forsythia suspense Oleaceae  
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134 Dendrobium nobile Orchidaceae  
135 Pleione bulbocadiodes Orchidaceae  
136 Paenia lacttiflora Paeoniaceae  
137 Paenia suffauticosa Paeoniaceae  
138 Passiflora molissima Passifloraceae  
139 Passiflora caerulea Passifloraceae  
140 Passiflora edulis Passifloraceae  
141 Passiflora alata Passifloraceae  
142 Passiflora aurantia Passifloraceae  
143 Passiflora quadrangularis Passifloraceae  
144 Passiflora cinnabirana Passifloraceae  
145 Plantago asiatica Plantaginaceae  
146 Imperata cylindrica rhizome Poaceae  
147 Coix lacrymajobi Poaceae  
148 Rheum officinale Polygonaceae  
149 Polygonum aviculare Polygonaceae  
150 Rheum palmatum root Polygonaceae  
151 Polygonum cuspidatum Polygonaceae  
152 Poria cocos Polyporaceae  
153 Lysimachia christinae Primulaceae  
154 Duscheshea indica Rosaceae  
155 Sanguisorba officinalis Rosaceae  
156 Crataegus rhipidophylla Rosaceae  
157 Gardenia jasminoides Rubiaceae  
158 Randa chartaceae Rubiaceae  
159 Canthium oleifolium Rubiaceae  
160 Uncaria rhyncophylla Rubiaceae  
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161 Hydeotis diffusa Rubiaceae  
162 Scutella barbata Rubiaceae  
163 Canthium pittsworthium Rubiaceae  
164 Guettarda crispiflora Rubiaceae  
165 Palicourea guianensis Rubiaceae  
166 Hedyotis centranthoides Rubiaceae  
167 Pellodendron Chinese bark Rutaceae  
168 Viscum colaratum Santalaceae  
169 Sonilax glabra Smilaceae  
170 Solanum nigrum Solanaceae  
171 solanum lyratum Solanaceae  
172 Chinese lantern Solanaceae  
173 Wikstroemia indica Thymelaeceae  
174 Viola pubescence Violaceae  
175 Leonia triandra Violaceae  
176 Melicytus dentatus (Victoria) Violaceae  
177 Melicytus dentatus (Blue Mountains) Violaceae  
178 Glospermum sphaerocarpum Violaceae  
179 Melicytus obovatus Violaceae  
180 Melicytus angustifolius Violaceae  
181 Viola arcuata Violaceae  
182 Viola diffusa Violaceae  
183 Viola inconspicua Violaceae  
184 Viola nagasawae  Violaceae  
185 Viola riviniana Violaceae  
186 Viola Rococco Frilled Mix Violaceae  
187 Swiss giants Violaceae  
188 Pansy Arkwright Ruby Violaceae  
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189 Pansy Clear Crystal Black Violaceae  
190 Pansy Clear Crystal Scarlet Violaceae  
191 Pansy Clear Crystal Space Blue Violaceae  
192 Pansy Dreams of Fire Violaceae  
193 Pansy Swiss Giant Ullswater Violaceae  
194 Viola Admiration Violaceae  
195 Viola Blue Perfection Violaceae  
196 Viola Queen Charlotte Violaceae  
197 Viola White Perfection Violaceae  
198 Viola King Henry Violaceae  
199 Viola Prince John Violaceae  
200 Pansy Swiss Giants Rhine Gold Violaceae  
201 Curcuma aromatica Zingiberaceae  
202 Alphina officcinarum Zingiberaceae  
203 Carcuma wenywjin  Zingiberaceae  
204 Curcuma zedoaria Zingiberaceae  
 
 Plant species from 186 to 200 are hybrid varieties which have been named after their 
local names.  
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Table 2. List of plant species identified with cyclotides 
S. No Plant species Family Source 
1 Hedyotis centranthoides Rubiaceae Hawaiian Islands 
2 Palicourea guianensis Rubiaceae Botanical Ark, Cairns 
3 Glospermum sphaerocarpum Violaceae Universidad Tecnológica de Pereira 
4 Leonia triandra “ “ 
5 Melicytus angustifolius “ RBG Melbourne 
6 Melicytus obovatus “ “ 
7 Melicytus dentatus VC “ Blue Mountains Botanic Garden, Mount Tomah 
8 Melicytus dentatus BM “ “ 
9 Pansy Clear Crystal Scarlet “ Australian Seed Pty Ltd. 
10 Pansy Clear Crystal Space Blue “ “ 
11 Pansy Dream Fire “ “ 
12 Pansy Swiss Giants Rhine Gold “ “ 
13 Viola Arkwright Ruby large Fls “ “ 
14 Viola King Henry “ “ 
15 Viola Queen Charlotte Sweet Violet “ “ 
16 Viola Swiss Giant Ullswater “ “ 
17 Viola arcuata Bl. “ Taiwan 
18 Viola cornuta Admiration “ Australian Seed Pty Ltd. 
19 Viola cornuta Blue Perfection “ “ 
20 Viola cornuta Prince John “ “ 
21 Viola cornuta White Perfection “ “ 
22 Viola diffusa Ging. “ Taiwan 
23 Viola inconspicua Blume subsp. “ “ 
24 Viola nagasawae Makino “ “ 
25 Viola pubescence “ Blue Mountains Botanic Garden, Mount Tomah 
26 Viola riviniana “ RBG Melbourne 
27 Viola rococco Frilled Mix “ Australian Seed Pty Ltd. 
28 Viola tricolor Heartsease Wild Pansy “ “ 
29 Viola tricolor Maxima “ “ 
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Table 3: Amino acid analysis of mela 2.   
AMINO ACID RATIO  RATIO FOUND 
Histidine 0 ND 
Arginine 0 1.02 
Serine 1 1.11 
Glycine 4 4.52 
Aspartic 
Acid/Asparagine 1 1.12 
Glutamic 
Acid/Glutamine 1 1.09 
Threonine 4 4.25 
Alanine 0 0.86 
Proline 3 3.16 
Cysteine/Cystine 6 ND 
Lysine 5 ND 
Tyrosine 2 2.06 
Methionine 0 0 
Valine 0 0 
Isoleucine 0 0 
Leucine 1 1.11 
Phenylalanine 1 1.19 
Tryptophan 0 ND 
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Table 4: Cyclotides with four or more positive charges, but not classified as Lys-rich cyclotides 
Name + 
(ve) 
Lys Arg His S* Peptide sequence 
caripe 4 5 0 3 2 B LI--- CSSTC LRIP---- C LSPR---- CTC RHHI--- CYLN 
caripe 6 5 0 4 1 B GAI-- CTGTC FRNP---- C LSRR---- CTC RHYI--- CYLN 
hcf-1 4 0 3 1 B GIP-- CGESC HYIP---- C VTSAIG-- CSC RNRS--- CMRN 
Hcf-1variant 4 0 3 1 B GIP-- CGESC HIP----- C VTSAIG-- CSC RNRS--- CMRN 
caripe 8 4 3 1 0 B GVIP- CGESC VFIP---- C ITAAIG-- CSC KKKV--- CYRN 
circulin D 4 3 0 1 B KIP-- CGESC VWIP---- C VTSIFN-- CKC ENKV--- CYHD 
circulin E 4 3 0 1 B KIP-- CGESC VWIP---- C LTSVFN-- CKC ENKV--- CYHD 
cO26 4 3 1 0 M GSIPA CGESC FRGK---- C YTPG---- CSC SKYPL-- CAKD 
hedyotide B1 4 2 2 0 B GTR-- CGETC FVLP---- C WSAKFG-- CYC QKGF--- CYRN 
mram 11 4 2 1 1 M GHPT- CGETC LLGT---- C YTPG---- CTC KRPV--- CYKN 
Oak7 cyclotide 4 2 1 1 B GSH-- CGETC FFFG---- C YKPG---- CSC DELRQ-- CYKN 
palicourein 4 1 3 0 B GDPTF CGETC RVIPV--- C TYSAALG- CTC DDRSDGL CKRN 
hyfl F 4 2 0 2 B SIS-- CGETC TTFN---- C WIPN---- CKC NHHDKV- CYWN 
viba 14 7 0 6 1 B GRL-- CGERC VIERTRAW C RTVG---- CIC SLHTLE- CVRN 
vibi_J 4 4 0 0 B GTFP- CGESC VWIP---- C ISKVIG-- CAC KSKV--- CYKN 
 
S*: subfamily, B: bracelet,  M: Möbius 
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Figure 1: De novo sequencing of mela 2. (A) MALDI-MS of mela 2 from native, reduction & 
alkylation and endoGlu-C digestion (B) ESI-MS/MS of reduced, alkylated and endoGlu-C digested 
precursor of mela 2 (m/z 1154.18
3+
, 3459.54.2 Da) (C) MALDI-MS/MS of the precursor ion at m/z 
1766.6 and (C) MALDI-MS/MS of the precursor ion at m/z 1527.5 obtained from tryptic digest. 
Sequence was deduced from b- and y-ion series.  
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Figure 2: TOCSY and NOESY spectra for mech 2 and 3 
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Figure 3: TOCSY and NOESY spectra for mela 2. 
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Figure 4: Identification of N and D isomers as mech 2 and 3. (A) Mass spectrum of alkylated and 
linearized mech 2 precursor of expected m/z 3491.4. (B) The MS/MS fragment ions before the Asp, 
y7 (m/z 733.3) and b21 (m/z 1322.7
2+
), are as expected (both m/z and 
13
C pattern). The isotopic 
distributions observed for MS/MS fragment ions after the Asp, y8 (C; m/z 848.4) and b23 (D; m/z 
1408.7.0
2+
) are not as expected, with additional peaks observed corresponding to the presence of an 
Asn isoform and showing deviation from the expected 
13
C isotope peak pattern. For clarity, the y10 
(C; m/z 1139.6) and b24 (D; m/z 1465.2
2+
) ions are also shown.   
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Figure 5: TOCSY and NOESY spectra for mela 6 and 7 
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Figure 6: NMR and modeling studies of the Lys-rich cyclotides. 
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List of cyclotides used for statistics presented in Table 3.2 (Chapter 3). 
caripe_1   GVIPCGESCVFIPCISTVIGCSCKDKVCYRN 
caripe_2   GIPCGESCVFIRCTITALLGCSCSNNVCYKN 
caripe_4  LICSSTCLRIPCLSPRCTCRHHICYLN 
caripe_6  GAICTGTCFRNPCLSRRCTCRHYICYLN 
caripe_7  GIPCGESCVFIPCTVTALLGCSCKNKVCYRNGLN 
caripe_8  GVIPCGESCVFIPCITAAIGCSCKKKVCYRN 
CD-1   GADGFCGESCYVIPCISYLVGCSCDTIEKVCKRN 
chacur_1  GLPVCGETCVGGTCNTPGCTCSWPICTRN 
chassatide_C1  GDACGETCFTGICFTAGCSCNPWPTCTRN 
chassatide_C10 GEYCGESCYLIPCFTPGCYCVSRQCVNKN 
chassatide_C12 EYCGESCYLIPCFTPGCYCVSRQCVNKN 
chassatide_C13 GFPCAESCVYIPCTVTALLGCSCRNRVCYRN 
chassatide_C14 GIPCAESCVYIPCTITALFGCSCKDKVCYNN 
chassatide_C15 GIPCAESCVYIPCTITALLGCSCKDKVCYKN 
chassatide_C16 GVPCAESCVYIPCTITALFGCSCKDKVCYNN 
chassatide_C18 GIPCGESCVFIPCISALLGCSCSNKVCYNN 
chassatide_C2  GIPCAESCVWIPCTITALMGCSCKNN 
chassatide_C3  GIPCGESCWIPCISSALGCSCKNKVCYRN 
chassatide_C4  GASCGETCFTGICFTAGCSCNPWPTCTRN 
chassatide_C5  GVIPCGESCVFIPCISSVVGCSCKNKVCYRN 
chassatide_C6  GVIPCGESCVFIPCISSVIGCSCKNKVCYRN 
chassatide_C9  GIPCGESCVFIPCVTTVIGCSCKDKVCYNN 
circulin_A  GIPCGESCVWIPCISAALGCSCKNKVCYRN 
circulin_B  GVIPCGESCVFIPCISTLLGCSCKNKVCYRN 
circulin_C  GIPCGESCVFIPCITSVAGCSCKSKVCYRN 
circulin_D  KIPCGESCVWIPCVTSIFNCKCENKVCYHD 
circulin_E  KIPCGESCVWIPCLTSVFNCKCENKVCYHD 
cliotide_T12  GIPCGESCVFIPCITGAIGCSCKSKVCYRD 
cliotide_T2  GEFLKCGESCVQGECYTPGCSCDWPICKKN 
cliotide_T8  GIPCGESCVFIPCISSVVGCSCKSKVCYNN 
cliotide_T9  GIPCGESCVFIPCLTTVVGCSCKNKVCYNN 
cO26   GSIPACGESCFRGKCYTPGCSCSKYPLCAKD 
cO27   GSIPACGESCFKGWCYTPGCSCSKYPLCAKD 
cO28   GLPVCGETCVGGTCNTPGCSCSWPVCFRD 
cO29   GIPCGESCVWIPCISGAIGCSCKSKVCYKN 
cO30   GIPCGESCVWIPCISSAIGCSCKNKVCFKN 
cO31   GLPVCGETCVGGTCNTPGCSCSIPVCTRN 
cO32   GAPVCGETCFGGTCNTPGCTCDPWPVCTND 
cO33   GLPVCGETCVGGTCNTPYCTCSWPVCTRD 
cO34   GLPVCGETCVGGTCNTEYCTCSWPVCTRD 
cO35   GLPVCGETCVGGTCNTPYCFCSWPVCTRD 
Co36   GLPTCGETCFGGTCNTPGCTCDPFPVCTHD 
Cter_A  GVIPCGESCVFIPCISTVIGCSCKNKVCYRN 
Cter_B   GVPCAESCVWIPCTVTALLGCSCKDKVCYLN 
Cter_C   GVPCAESCVWIPCTVTALLGCSCKDKVCYLD 
Cter_D  GIPCAESCVWIPCTVTALLGCSCKDKVCYLN 
Cter_E   GIPCAESCVWIPCTVTALLGCSCKDKVCYLD 
Cter_F   GIPCGESCVFIPCISSVVGCSCKSKVCYLD 
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Cter_G  GLPCGESCVFIPCITTVVGCSCKNKVCYNN 
Cter_H  GLPCGESCVFIPCITTVVGCSCKNKVCYND 
Cter_I   GTVPCGESCVFIPCITGIAGCSCKNKVCYIN 
Cter_J   GTVPCGESCVFIPCITGIAGCSCKNKVCYID 
Cter_K  HEPCGESCVFIPCITTVVGCSCKNKVCYN 
Cter_L   HEPCGESCVFIPCITTVVGCSCKNKVCYD 
Cter_M  GLPTCGETCTLGTCYVPDCSCSWPICMKN 
Cter_N  GSAFCGETCVLGTCYTPDCSCTALVCLKN 
Cter_O  GIPCGESCVFIPCITGIAGCSCKSKVCYRN 
Cter_P   GIPCGESCVFIPCITAAIGCSCKSKVCYRN 
Cter_Q  GIPCGESCVFIPCISTVIGCSCKNKVCYRN 
Cter_R   GIPCGESCVFIPCTVTALLGCSCKDKVCYKN 
cyclopsychotride_A SIPCGESCVFIPCTVTALLGCSCKSKVCYKN 
cycloviolacin_H1 GIPCGESCVYIPCLTSAIGCSCKSKVCYRN 
cycloviolacin_H2 SAIACGESCVYIPCFIPGCSCRNRVCYLN 
cycloviolacin_H3 GLPVCGETCFGGTCNTPGCICDPWPVCTRN 
cycloviolacin_H4 GIPCAESCVWIPCTVTALLGCSCSNNVCYN 
cycloviolacin_O1 GIPCAESCVYIPCTVTALLGCSCSNRVCYN 
cycloviolacin_O10 GIPCGESCVYIPCLTSAVGCSCKSKVCYRN 
cycloviolacin_O11 GTLPCGESCVWIPCISAVVGCSCKSKVCYKN 
cycloviolacin_O12 GLPICGETCVGGTCNTPGCSCSWPVCTRN 
cycloviolacin_O13 GIPCGESCVWIPCISAAIGCSCKSKVCYRN 
cycloviolacin_O15 GLVPCGETCFTGKCYTPGCSCSYPICKKN 
cycloviolacin_O16 GLPCGETCFTGKCYTPGCSCSYPICKKIN 
cycloviolacin_O17 GIPCGESCVWIPCISAAIGCSCKNKVCYRN 
cycloviolacin_O18 GIPCGESCVYIPCTVTALAGCKCKSKVCYN 
cycloviolacin_O19 GTLPCGESCVWIPCISSVVGCSCKSKVCYKD 
cycloviolacin_O2 GIPCGESCVWIPCISSAIGCSCKSKVCYRN 
cycloviolacin_O20 GIPCGESCVWIPCLTSAIGCSCKSKVCYRD 
cycloviolacin_O21 GLPVCGETCVTGSCYTPGCTCSWPVCTRN 
cycloviolacin_O22 GLPICGETCVGGTCNTPGCTCSWPVCTRN 
cycloviolacin_O23 GLPTCGETCFGGTCNTPGCTCDSSWPICTHN 
cycloviolacin_O24 GLPTCGETCFGGTCNTPGCTCDPWPVCTHN 
cycloviolacin_O25 DIFCGETCAFIPCITHVPGTCSCKSKVCYFN 
cycloviolacin_O3 GIPCGESCVWIPCLTSAIGCSCKSKVCYRN 
cycloviolacin_O4 GIPCGESCVWIPCISSAIGCSCKNKVCYRN 
cycloviolacin_O5 GTPCGESCVWIPCISSAVGCSCKNKVCYKN 
cycloviolacin_O6 GTLPCGESCVWIPCISAAVGCSCKSKVCYKN 
cycloviolacin_O7 SIPCGESCVWIPCTITALAGCKCKSKVCYN 
cycloviolacin_O8 GTLPCGESCVWIPCISSVVGCSCKSKVCYKN 
cycloviolacin_O9 GIPCGESCVWIPCLTSAVGCSCKSKVCYRN 
cycloviolacin_T1 GIPVCGETCVGGTCNTPGCSCSWPVCTRN 
cycloviolacin_Y1 GGTIFDCGETCFLGTCYTPGCSCGNYGFCYGTN 
cycloviolacin_Y2 GGTIFDCGESCFLGTCYTAGCSCGNWGLCYGTN 
cycloviolacin_Y3 GGTIFDCGETCFLGTCYTAGCSCGNWGLCYGTN 
cycloviolacin_Y4 GVPCGESCVFIPCITGVIGCSCSSNVCYLN 
cycloviolacin_Y5 GIPCAESCVWIPCTVTALVGCSCSDKVCYN 
cycloviolin_A  GVIPCGESCVFIPCISAAIGCSCKNKVCYRN 
cycloviolin_B  GTACGESCYVLPCFTVGCTCTSSQCFKN 
cycloviolin_C  GIPCGESCVFIPCLTTVAGCSCKNKVCYRN 
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cycloviolin_D  GFPCGESCVFIPCISAAIGCSCKNKVCYRN 
Globa_A  GIPCGESCVFIPCITAAIGCSCKTKVCYRN 
Globa_B  GVIPCGESCVFIPCISAVLGCSCKSKVCYRN 
Globa_C  APCGESCVFIPCISAVLGCSCKSKVCYRN 
Globa_D  GIPCGETCVFMPCISGPMGCSCKHMVCYRN 
Globa_F  GSFPCGESCVFIPCISAIAGCSCKNKVCYKN 
Glopa_A  GGSIPCIETCVWTGCFLVPGCSCKSDKKCYLN 
Glopa_B  GGSVPCIETCVWTGCFLVPGCSCKSDKKCYLN 
Glopa_C  GDIPLCGETCFEGGNCRIPGCTCVWPFCSKN 
Glopa_D  GVPCGESCVWVPCTVTALMGCSCVREVCRKD 
Glopa_E  GIPCAESCVWIPCTVTKMLGCSCKDKVCYN 
hcf-1   GIPCGESCHYIPCVTSAIGCSCRNRSCMRN 
hcf-1_variant  GIPCGESCHIPCVTSAIGCSCRNRSCMRN 
hedyotide_B1  GTRCGETCFVLPCWSAKFGCYCQKGFCYRN 
htf-1   GIPCGDSCHYIPCVTSTIGCSCTNGSCMRN 
Hyfl_A  SISCGESCVYIPCTVTALVGCTCKDKVCYLN 
Hyfl_B  GSPIQCAETCFIGKCYTEELGCTCTAFLCMKN 
Hyfl_C  GSPRQCAETCFIGKCYTEELGCTCTAFLCMKN 
Hyfl_D  GSVPCGESCVYIPCFTGIAGCSCKSKVCYYN 
Hyfl_E  GEIPCGESCVYLPCFLPNCYCRNHVCYLN 
Hyfl_F   SISCGETCTTFNCWIPNCKCNHHDKVCYWN 
Hyfl_I   GIPCGESCVFIPCISGVIGCSCKSKVCYRN 
Hyfl_J   GIACGESCAYFGCWIPGCSCRNKVCYFN 
Hyfl_K   GTPCGESCVYIPCFTAVVGCTCKDKVCYLN 
Hyfl_L  GTPCAESCVYLPCFTGVIGCTCKDKVCYLN 
Hyfl_M  GNIPCGESCIFFPCFNPGCSCKDNLCYYN 
Hypa_A  GIPCAESCVYIPCTITALLGCSCKNKVCYN 
kalata_B1  GLPVCGETCVGGTCNTPGCTCSWPVCTRN 
kalata_B10  GLPTCGETCFGGTCNTPGCSCSSWPICTRD 
kalata_B10_linear GLPTCGETCFGGTCNTPGCSCSSWPICTRD 
kalata_B11  GLPVCGETCFGGTCNTPGCSCTDPICTRD 
kalata_B12  GSLCGDTCFVLGCNDSSCSCNYPICVKD 
kalata_B13  GLPVCGETCFGGTCNTPGCACDPWPVCTRD 
kalata_B14  GLPVCGESCFGGTCNTPGCACDPWPVCTRD 
kalata_B15  GLPVCGESCFGGSCYTPGCSCTWPICTRD 
kalata_B16  GIPCAESCVYIPCTITALLGCKCQDKVCYD 
kalata_B17  GIPCAESCVYIPCTITALLGCKCKDQVCYN 
kalata_B18  GVPCAESCVYIPCISTVLGCSCSNQVCYRN 
kalata_B19  GFPCGESCVYVPCLTAAIGCSCSNKVCYKN 
kalata_B2  GLPVCGETCFGGTCNTPGCSCTWPICTRD 
kalata_B3  GLPTCGETCFGGTCNTPGCTCDPWPICTRD 
kalata_B4  GLPVCGETCVGGTCNTPGCTCSWPVCTRD 
kalata_B5  GTPCGESCVYIPCISGVIGCSCTDKVCYLN 
kalata_B6  GLPTCGETCFGGTCNTPGCSCSSWPICTRN 
kalata_B7  GLPVCGETCTLGTCYTQGCTCSWPICKRN 
kalata_B8  GSVLNCGETCLLGTCYTTGCTCNKYRVCTKD 
kalata_B9  GSVFNCGETCVLGTCYTPGCTCNTYRVCTKD 
kalata_B9_linear GSVFNCGETCVLGTCYTPGCTCNTYRVCTKD 
kalata_S  GLPVCGETCVGGTCNTPGCSCSWPVCTRN 
mram_1  GSIPCGESCVYIPCISSLLGCSCKSKVCYKN 
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mram_10  GVIPCGESCVFIPCISSVLGCSCKNKVCYRN 
mram_11  GHPTCGETCLLGTCYTPGCTCKRPVCYKN 
mram_12  GSAILCGESCTLGECYTPGCTCSWPICTKN 
mram_13  GHPICGETCVGNKCYTPGCTCTWPVCYRN 
mram_14  GSIPCGEGCVFIPCISSIVGCSCKSKVCYKN 
mram_2  GIPCAESCVYIPCLTSAIGCSCKSKVCYRN 
mram_4  GSIPCGESCVFIPCISSVVGCSCKNKVCYKN 
mram_5  GTIPCGESCVFIPCLTSAIGCSCKSKVCYKN 
mram_6  GSIPCGESCVYIPCISSLLGCSCESKVCYKN 
mram_7  GSIPCGESCVFIPCISSIVGCSCKSKVCYKN 
mram_8  GIPCGESCVFIPCLTSAIGCSCKSKVCYRN 
mram_9  GVPCGESCVWIPCLTSIVGCSCKNNVCTLN 
Oak6_cyclotide_1 GLPVCGETCFGGTCNTPGCACDPWPVCTRN 
Oak6_cyclotide_2 GLPICGETCFGGTCNTPGCICDPWPVCTRD 
Oak7_cyclotide GSHCGETCFFFGCYKPGCSCDELRQCYKN 
Oak8_cyclotide GVPCGESCVFIPCLTAVVGCSCSNKVCYLN 
Palicourein  GDPTFCGETCRVIPVCTYSAALGCTCDDRSDGLCKRN 
paltet_1  GLPICGETCFTGTCNTPGCTCSYPVCTRN 
Parigidin-br1  GGSVPCGESCVFIPCITSLAGCSCKNKVCYYD 
Phyb_A  GIGCGESCVWIPCVSAAIGCSCSNKICYRN 
Phyb_B  GVPCGESCVWMYCISAAMGCSCRNKVCYRN 
Phyb_C  GIPCGESCVWMYCITATMGCSCRNKVCYKN 
Phyb_D  GIPCGESCMWIPCISAAIGCSCTNHVCYKN 
Phyb_E  GIPCGESCVWIPCISGVQGCSCSNKICYRN 
Phyb_F  GIPCGGSCVWIPCISGVQGCSCSNKICYRN 
Phyb_G  GIPCGESCAWIPCISAVQGCSCRNKICYRN 
Phyb_H  GLPCGESCIWIECISGAIGCSCRNKVCYRN 
Phyb_I   GIPCGESCIWIPCTTTALLGCSCSNKVCYKN 
Phyb_J  SYTCGESCLWIPCTVTAAFGCYCSNKVCVKD 
Phyb_K  STDCGEPCVYIPCTITALLGCSCLNKVCVRP 
Phyb_L  QSISCAETCVWIPCATSLIGCSCVNSICTYTN 
PS-1   GFIPCGETCIWDKTCHAAGCSCSVANICVRN 
psybra_1  GLPICGETCTLGTCNTPGCTCSWPICTKN 
psyle_A  GIACGESCVFLGCFIPGCSCKSKVCYFN 
psyle_B  GIPCGETCVAFGCWIPGCSCKDKLCYYD 
psyle_D  GIPCGESCVFIPCTVTALLGCSCQNKVCYRD 
psyle_E  GVIPCGESCVFIPCISSVLGCSCKNKVCYRD 
psyle_F  GVIPCGESCVFIPCITAAVGCSCKNKVCYRD 
psypoe_1  GSVICGETCFTTVCNTPGCYCGAYXCTRN 
tricyclon_A  GGTIFDCGESCFLGTCYTKGCSCGEWKLCYGTN 
tricyclon_B  GGTIFDCGESCFLGTCYTKGCSCGEWKLCYGEN 
vaby_A  GLPVCGETCAGGTCNTPGCSCSWPICTRN 
vaby_B  GLPVCGETCAGGTCNTPGCSCTWPICTRN 
vaby_C  GLPVCGETCAGGRCNTPGCSCSWPVCTRN 
vaby_D  GLPVCGETCFGGTCNTPGCTCDPWPVCTRN 
vaby_E  GLPVCGETCFGGTCNTPGCSCDPWPVCTRN 
varv_peptide_B GLPVCGETCFGGTCNTPGCSCDPWPMCSRN 
varv_peptide_C GVPICGETCVGGTCNTPGCSCSWPVCTRN 
varv_peptide_D GLPICGETCVGGSCNTPGCSCSWPVCTRN 
varv_peptide_F GVPICGETCTLGTCYTAGCSCSWPVCTRN 
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varv_peptide_G GVPVCGETCFGGTCNTPGCSCDPWPVCSRN 
varv_peptide_H GLPVCGETCFGGTCNTPGCSCETWPVCSRN 
vhl-1   SISCGESCAMISFCFTEVIGCSCKNKVCYLN 
vhl-2   GLPVCGETCFTGTCYTNGCTCDPWPVCTRN 
vhr1   GIPCAESCVWIPCTVTALLGCSCSNKVCYN 
Viba_1  GIPCGEGCVYLPCFTAPLGCSCSSKVCYRN 
Viba_10  GIPCAESCVYLPCVTIVIGCSCKDKVCYN 
Viba_11  GIPCGESCVWIPCISGAIGCSCKSKVCYRN 
Viba_12  GIPCAESCVWIPCTVTALLGCSCKDKVCYN 
Viba_13  TIPCAESCVWIPCTVTALLGCSCKDKVCYN 
Viba_14  GRLCGERCVIERTRAWCRTVGCICSLHTLECVRN 
Viba_15  GLPVCGETCVGGTCNTPGCACSWPVCTRN 
Viba_16  GLPICGETCTLGTCYTVGCTCSWPICTRN 
Viba_17  GLPVCGETCVGGTCNTPGCGCSWPVCTRN 
Viba_2  GIPCGESCVYLPCFTAPLGCSCSSKVCYRN 
Viba_3  GIPCGESCVWIPCLTAAIGCSCSSKVCYRN 
Viba_4  GVPCGESCVWIPCLTSAIGCSCKSSVCYRN 
Viba_5  GIPCGESCVWIPCLTATIGCSCKSKVCYRN 
Viba_6  GIPCGESCVLIPCISSVIGCSCKSKVCYRN 
Viba_7  GVIPCGESCVFIPCISSVIGCSCKSKVCYRN 
Viba_8  GAGCIETCYTFPCISEMINCSCKNSRCQKN 
vibi_A   GLPVCGETCFGGTCNTPGCSCSYPICTRN 
vibi_B   GLPVCGETCFGGTCNTPGCTCSYPICTRN 
vibi_C   GLPVCGETCAFGSCYTPGCSCSWPVCTRN 
vibi_D   GLPVCGETCFGGRCNTPGCTCSYPICTRN 
vibi_E   GIPCAESCVWIPCTVTALIGCGCSNKVCYN 
vibi_F   GTIPCGESCVFIPCLTSALGCSCKSKVCYKN 
vibi_G   GTFPCGESCVFIPCLTSAIGCSCKSKVCYKN 
vibi_H   GLLPCAESCVYIPCLTTVIGCSCKSKVCYKN 
vibi_I   GIPCGESCVWIPCLTSTVGCSCKSKVCYRN 
vibi_J   GTFPCGESCVWIPCISKVIGCACKSKVCYKN 
vibi_K   GIPCGESCVWIPCLTSAVGCPCKSKVCYRN 
vico_A  GSIPCAESCVYIPCFTGIAGCSCKNKVCYYN 
vico_B   GSIPCAESCVYIPCITGIAGCSCKNKVCYYN 
vigno_1  GLPLCGETCAGGTCNTPGCSCSWPVCVRN 
vigno_10  GTIPCGESCVWIPCISSVVGCSCKSKVCYKD 
vigno_2  GSSPLCGETCAGGTCNTPGCSCSWPVCVRD 
vigno_3  GLPLCGETCVGGTCNTPGCSCSWPVCTRN 
vigno_4  GLPLCGETCVGGTCNTPACSCSWPVCTRN 
vigno_5  GLPLCGETCVGGTCNTPGCSCGWPVCVRN 
vigno_6  GIPCGESCVWIPCISSAIGCSCKGSKVCYRN 
vigno_7  GTLPCGESCVWIPCISSVVGCSCKNKVCYKN 
vigno_8  GIPCGESCVWIPCITSAVGCSCKSKVCYRN 
vigno_9  GIPCGESCVWIPCISSALGCSCKSKVCYRN 
violapeptide_1 GLPVCGETCVGGTCNTPGCSCSRPVCTXN 
viphi_A  GSIPCGESCVFIPCISSVIGCACKSKVCYKN 
viphi_B  GLPVCGETCTIGTCYTAGCTCSWPICTRN 
viphi_C  GVPCGESCVYIPCITSVIGCSCSSKVCYIN 
viphi_D  GIPCGESCVFIPCISSVIGCSCSSKVCYRN 
viphi_E  GSIPCGESCVFIPCISAVIGCSCSNKVCYKN 
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viphi_F  GSIPCGESCVFIPCISAIIGCSCSSKVCYKN 
viphi_G  GSIPCGESCVFIPCISAIIGCSCSNKVCYKN 
viphi_H  GIPCAESCVWIPCTVTAIVGCSCSWGVCYN 
vitri_A   GIPCGESCVWIPCITSAIGCSCKSKVCYRN 
vitri_B   GVPICGESCVGGTCNTPGCSCSWPVCTTN 
vitri_C   GLPICGETCVGGTCNTPGCFCTWPVCTRN 
vitri_D   GLPVCGETCFTGSCYTPGCSCNWPVCNRN 
vitri_E   GLPVCGETCVGGTCNTPGCSCSWPVCFRN 
vitri_F   GLTPCGESCVWIPCISSVVGCACKSKVCYKD 
Vo2729  GLPVCGETCVGGTCYTPGCSCSWPVCTRN 
Vo2873  GLPVCGETCVGGTCNTPGCTCSWPVCTHD 
Vo2923  GLPVCGETCVGGTCNTPGCSCSWPVCFRN 
Vo3006  GLPTCGETCFGGTCNTPGCTCDPFPVCTHN 
Vo3029a  GAPTCGETCFGGTCNTPGCTCDPWPVCVYN 
Vo3206  GSIPACGESCFRGKCYTPGCSCSKYPLCAKN 
Vo3236  GSIPACGESCFKGWCYTPGCSCSKYPLCAKN 
vocC   GLPVCGETCVGGTCNTPGCSCSWPVCIRN 
vodo_M  GAPICGESCFTGKCYTVQCSCSWPVCTRN 
vodo_N  GLPVCGETCTLGKCYTAGCSCSWPVCYRN 
Vpf-1   GIPCGESCVFIPCLTAAIGCSCRSKVCYRN 
Vpl-1   GSQSCGESCVLIPCISGVIGCSCSSMICYFN 
 
 
